def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
|
|
|
Filed by the Registrant
þ |
|
Filed by a Party other than the Registrant
o |
|
|
Check the appropriate box: |
|
|
|
o Preliminary Proxy Statement |
|
o
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2)) |
|
þ Definitive Proxy Statement |
|
o Definitive Additional Materials |
|
o
Soliciting Material Pursuant to §240.14a-12 |
Patterson-UTI Energy,
Inc.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
þ No fee required. |
|
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11. |
|
|
|
1) Title of each class of securities to which transaction applies: |
|
|
|
2) Aggregate number of securities to which transaction applies: |
|
|
|
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined): |
|
|
|
4) Proposed maximum aggregate value of transaction: |
|
|
|
o Fee paid previously with preliminary materials. |
|
|
|
o Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing. |
|
|
|
1) Amount Previously Paid: |
|
|
|
2) Form, Schedule or Registration Statement No.: |
April 16,
2009
Dear Stockholder:
We cordially invite you to attend Patterson-UTI Energy,
Inc.s annual stockholders meeting. The annual
meeting will be held Wednesday, June 3, 2009, at
10:00 a.m., local time, at the Hilton Houston North Hotel,
12400 Greenspoint Drive, Houston, Texas 77060.
This year we are pleased to take advantage of Securities and
Exchange Commission rules that allow us to furnish these proxy
materials and our annual report primarily over the Internet. We
believe that posting these materials on the Internet enables us
to provide stockholders with the information that they need
quickly, while lowering our costs of printing and delivery and
conserving natural resources. We encourage you to vote via the
Internet and follow the links to our proxy statement and annual
report, which are both available at www.proxyvote.com.
For those stockholders who have elected to receive their proxy
materials in the mail, please review our proxy statement and
annual report and vote via the Internet, by telephone or using
your proxy card.
Your vote is important to us. Please review your proxy materials
carefully and send in your vote today.
Thank you for your support.
Sincerely,
|
|
|
|
|
|
Mark S. Siegel
|
|
Douglas J. Wall
|
Chairman of the Board
|
|
President and Chief Executive Officer
|
TABLE OF CONTENTS
PATTERSON-UTI
ENERGY, INC.
450 Gears Road, Suite 500
Houston, Texas 77067
NOTICE OF
2009 ANNUAL MEETING OF STOCKHOLDERS
To Be Held June 3, 2009
The 2009 annual meeting of the stockholders of Patterson-UTI
Energy, Inc., a Delaware corporation
(Patterson-UTI), will be held Wednesday,
June 3, 2009, at 10:00 a.m., local time, at the Hilton
Houston North Hotel, 12400 Greenspoint Drive, Houston, Texas
77060 (the Meeting), for the following purposes:
|
|
|
|
|
to elect seven directors to the Board of Directors of
Patterson-UTI to serve until the next annual meeting of the
stockholders or until their respective successors are elected
and qualified;
|
|
|
|
to ratify the selection of PricewaterhouseCoopers LLP as the
independent registered public accounting firm of Patterson-UTI
for the fiscal year ending December 31, 2009; and
|
|
|
|
transact such other business as may properly come before the
Meeting or any adjournment or postponement thereof.
|
Stockholders of record at the close of business on April 6,
2009 are entitled to vote at the Meeting and any adjournment or
postponement thereof.
Your vote is important to us. Whether or not you plan to attend
the Meeting in person, we urge you to promptly vote your shares
via the Internet, by telephone, or if the accompanying proxy
statement was mailed to you, by completing, signing, dating and
returning your proxy card as soon as possible in the enclosed
postage prepaid envelope.
By order of the Board of Directors
William L. Moll, Jr.
General Counsel and Secretary
April 16, 2009
PATTERSON-UTI
ENERGY, INC.
450 Gears Road, Suite 500
Houston, Texas 77067
PROXY
STATEMENT
ANNUAL
MEETING OF STOCKHOLDERS
To Be Held June 3, 2009
GENERAL
INFORMATION ABOUT THE ANNUAL MEETING AND VOTING
The Board of Directors (the Board or Board of
Directors) of Patterson-UTI Energy, Inc., a Delaware
corporation (Patterson-UTI), has made these proxy
materials available to you on the Internet, or, upon your
request has delivered printed versions of these materials to you
by mail. Patterson-UTI is furnishing this proxy statement in
connection with the solicitation by the Board of Directors of
proxies to be voted at the 2009 annual meeting of stockholders
of Patterson-UTI (the Meeting). The Meeting will be
held Wednesday, June 3, 2009, at 10:00 a.m., local
time, at the Hilton Houston North Hotel, 12400 Greenspoint
Drive, Houston, Texas 77060, or at any adjournment thereof. The
Notice of Internet Availability of Proxy Materials (the
Notice) was mailed to each of Patterson-UTIs
stockholders (other than those who previously requested
electronic delivery) entitled to vote at the Meeting on or about
April 20, 2009.
Pursuant to the notice and access rules adopted by
the Securities and Exchange Commission (the SEC),
Patterson-UTI has elected to provide stockholders access to its
proxy materials over the Internet. Accordingly, Patterson-UTI
sent a Notice to all of its stockholders as of the record date.
The Notice includes instructions on how to access
Patterson-UTIs proxy materials over the Internet and how
to request a printed copy of these materials. In addition, by
following the instructions in the Notice, stockholders may
request to receive proxy materials in printed form by mail or
electronically by email on an ongoing basis.
Choosing to receive your future proxy materials by email will
save us the cost of printing and mailing documents to you and
will help conserve natural resources. If you choose to receive
future proxy materials by email, you will receive an email next
year with instructions containing a link to those materials and
a link to the proxy voting site. Your election to receive proxy
materials by email will remain in effect until you
terminate it.
If your shares are registered directly in your name with our
transfer agent, Continental Stock Transfer &
Trust Company, you are considered the stockholder of
record with respect to those shares, and the Notice was
sent directly to you.
If your shares are held in an account at a brokerage firm, bank,
broker-dealer, or other similar organization, then you are the
beneficial owner of shares held in street name, and
the Notice was forwarded to you by that organization. As a
beneficial owner, you have the right to direct that organization
on how to vote the shares held in your account.
Whether you are a stockholder of record or hold your
shares in street name, you may direct your vote
without attending the Meeting in person.
If you are a stockholder of record, you may vote by Internet or
by telephone by following the instructions on the Notice. If you
request printed copies of the proxy materials by mail, you may
also vote by signing and submitting your proxy card and
returning by mail or by submitting your vote by telephone. You
should sign your name exactly as it appears on the proxy card.
If you are signing in a representative capacity (for example, as
guardian, executor, trustee, custodian, attorney or officer of a
corporation), you should indicate your name and title or
capacity.
If you are the beneficial owner of shares held in street name,
you may be eligible to vote your shares electronically over the
Internet or by telephone by following the instructions on the
Notice. If you request printed copies of the proxy materials by
mail, you may also vote by signing the voter instruction card
provided by your bank
or broker and returning it by mail. If you provide specific
voting instructions by mail, telephone or the Internet, your
shares will be voted by your broker or nominee as you have
directed.
Properly submitted proxies received either by mail, Internet,
telephone or in person, in time to be counted for the Meeting
will be voted as you have directed in your proxy, unless you
revoke your proxy in the manner provided below. As to any matter
for which you give no direction in your proxy, your shares will
be voted as follows:
|
|
|
|
|
FOR the election of all of the nominees to the Board
of Directors;
|
|
|
|
FOR the ratification of PricewaterhouseCoopers LLP
as the independent registered public accounting firm of
Patterson-UTI for the fiscal year ending December 31,
2009; and
|
|
|
|
FOR or AGAINST any other proposals that
may be properly submitted at the Meeting at the discretion of
the persons named in the proxy.
|
If you are a stockholder of record, you may revoke your proxy
before the proxy is voted by either:
|
|
|
|
|
submitting a new proxy with a later date, including a proxy
submitted by the Internet or by telephone, in time to be counted
for the meeting;
|
|
|
|
notifying the Secretary of Patterson-UTI in writing before the
Meeting that you have revoked your proxy; or
|
|
|
|
attending the Meeting and voting in person.
|
If your shares are held in street name, you must obtain a proxy
executed in your favor from the stockholder of record (that is,
your brokerage firm, bank, broker-dealer or similar
organization) to be able to vote at the Meeting.
The Board of Directors is making this solicitation.
Patterson-UTIs officers and other employees, without
compensation other than regular compensation, may solicit
proxies by mail, email, the Internet, telephone, electronic
means and personal interview. Patterson-UTI does not intend to
retain a proxy solicitation firm to assist in the solicitation
of proxies of stockholders, but may do so if circumstances
warrant. Patterson-UTI will pay all costs associated with this
solicitation.
SHARES
OUTSTANDING AND VOTING RIGHTS
Only stockholders of record of Patterson-UTIs common
stock, $.01 par value per share (the Common
Stock), at the close of business on April 6, 2009 are
entitled to notice of and to vote at the Meeting or any
adjournment or postponement thereof. At the close of business on
April 6, 2009, there were 153,100,199 shares of Common
Stock issued and outstanding. Holders of record of Common Stock
on April 6, 2009 will be entitled to one vote per share on
all matters to properly come before the Meeting. A list of
stockholders entitled to notice of and to vote at the Meeting
will be made available during regular business hours at the
offices of Patterson-UTI Energy, Inc., 450 Gears Road,
Suite 500, Houston, Texas 77067, from May 19, 2009
through June 2, 2009 and at the Meeting for examination by
any stockholder for any purpose germane to the Meeting.
A quorum is necessary to transact business at the Meeting. A
majority of the shares of Common Stock outstanding on
April 6, 2009 will constitute a quorum. The shares held by
each stockholder who attends the Meeting in person, signs and
timely returns the form of proxy or properly votes using the
Internet or telephone will be counted for purposes of
determining the presence of a quorum at the Meeting.
PROPOSAL NO. 1
ELECTION
OF DIRECTORS
Patterson-UTIs bylaws provide that the number of members
of the Board of Directors shall be fixed either by amendment to
the bylaws or by resolution of the Board of Directors. Directors
are elected to serve until the next annual meeting of
stockholders and until their successors are elected and
qualified. Patterson-UTIs bylaws provide that the
affirmative vote of a plurality of the votes cast at the meeting
at which a quorum is present is required for the election of
directors. Shares as to which a stockholder withholds authority
to vote on the election of directors and shares as to which a
broker indicates that it does not have discretionary authority
to vote on the election of directors
2
will not be counted as voting thereon and will not affect the
election of the nominees receiving a plurality of the votes cast.
The enclosed form of proxy provides a means for you to either:
|
|
|
|
|
vote FOR the election of the nominees to the Board
of Directors listed below,
|
|
|
|
withhold authority to vote for one or more of the
nominees, or
|
|
|
|
withhold authority to vote for all of the nominees.
|
The Board of Directors recommends that you vote
FOR all of the nominees. Unless you
give contrary instructions in your proxy, your proxy will be
voted FOR the election of all of the nominees to the
Board of Directors. If any nominee should become unable or
unwilling to accept nomination or election, the person acting
under the proxy will vote for the election of such other person
as the Board of Directors may recommend. The Board has no
reason, however, to believe that any of the nominees will be
unable or unwilling to serve if elected.
There are no arrangements or understandings between any person
and any of the directors pursuant to which such director was
selected as a nominee for election at the Meeting. There are no
family relationships among any of the directors or executive
officers of Patterson-UTI.
Set forth below is the name, age, position and a brief
description of the business experience during at least the past
five years of each of the members of Patterson-UTIs Board
of Directors. Each current member of Patterson-UTIs Board
of Directors is a nominee for election to the Board of Directors.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Mark S. Siegel
|
|
|
58
|
|
|
Chairman of the Board and Director
|
Kenneth N. Berns
|
|
|
49
|
|
|
Senior Vice President and Director
|
Charles O. Buckner
|
|
|
64
|
|
|
Director
|
Curtis W. Huff
|
|
|
51
|
|
|
Director
|
Terry H. Hunt
|
|
|
60
|
|
|
Director
|
Kenneth R. Peak
|
|
|
63
|
|
|
Director
|
Cloyce A. Talbott
|
|
|
73
|
|
|
Director
|
Mark S. Siegel Mr. Siegel has served as
Chairman of the Board and as a director of Patterson-UTI since
May 2001. Mr. Siegel served as Chairman of the Board
and as a director of UTI Energy Corp. (UTI) from
1995 to May 2001, when UTI merged with and into Patterson-UTI.
Mr. Siegel has been President of REMY
Investors & Consultants, Incorporated (REMY
Investors) since 1993. From 1992 to 1993, Mr. Siegel
was President, Music Division, Blockbuster Entertainment Corp.
From 1988 through 1992, Mr. Siegel was an Executive Vice
President of Shamrock Holdings, Inc., a private investment
company, and Managing Director of Shamrock Capital Advisors,
Incorporated. Mr. Siegel holds a Bachelor of Arts degree
from Colgate University and a J.D. from the University of
California, Berkeley (Boalt Hall) School of Law.
Kenneth N. Berns Mr. Berns has served as
Senior Vice President of Patterson-UTI since April 2003 and as a
director of Patterson-UTI since May 2001. Mr. Berns served
as a director of UTI from 1995 to May 2001. Mr. Berns has
been an executive with REMY Investors since 1994. Mr. Berns
holds a Bachelors Degree in Business Administration from
San Diego State University and a Masters Degree in Taxation
from Golden Gate University.
Charles O. Buckner Mr. Buckner has
served as a director of Patterson-UTI since February 2007.
Mr. Buckner, a private investor, retired from the public
accounting firm of Ernst & Young LLP in 2002 after
35 years of service in a variety of client service and
administrative roles, including chairmanship of
Ernst & Youngs United States energy practice. He
presently serves as a director of Gateway Energy Corporation, a
public company in the oil and gas pipeline business.
Mr. Buckner is a Certified Public Accountant and holds a
Bachelor of Business Administration from the University of Texas
and a Masters of Business Administration from the University of
Houston.
Curtis W. Huff Mr. Huff has served as a
director of Patterson-UTI since May 2001 and served as a
director of UTI from 1997 to May 2001. Mr. Huff is the
President and Chief Executive Officer of Freebird Investments
LLC, a
3
private investment company, and has served in that capacity
since October 2002. Mr. Huff is also a Managing Director of
Intervale Capital, an oilfield service private equity firm that
Mr. Huff co-founded in 2006. Mr. Huff served as the
President and Chief Executive Officer of Grant Prideco, Inc., a
provider of drill pipe and other drill stem products, from
February 2001 to June 2002. From January 2000 to February 2001,
Mr. Huff served as Executive Vice President, Chief
Financial Officer and General Counsel of Weatherford
International, Inc., an oilfield services company. He served as
Senior Vice President and General Counsel of Weatherford from
May 1998 to January 2000. Prior to that time, Mr. Huff was
a partner with the law firm of Fulbright & Jaworski
L.L.P. and held that position for more than five years.
Mr. Huff holds a Bachelor of Arts degree and Juris
Doctorate from the University of New Mexico and a Masters of Law
from New York University School of Law.
Terry H. Hunt Mr. Hunt has served as a
director of Patterson-UTI since April 2003 and served as a
director of UTI from 1994 to May 2001. Mr. Hunt is an
energy consultant and investor. Mr. Hunt served as Senior
Vice President Strategic Planning of PPL
Corporation, an international energy and utility holding
company, from 1998 to 2000. Mr. Hunt served as the
President and Chief Executive Officer of Penn Fuel Gas, Inc., a
natural gas and propane distribution company, from 1992 to 1999.
Previously, Mr. Hunt was President and Chairman of Carnegie
Natural Gas Company, a gas distribution and transmission
company, and of Apollo Gas Company, a natural gas distributor.
Mr. Hunt holds a Bachelor of Engineering degree from the
University of Saskatchewan, Canada and a Masters of Business
Administration from Southern Methodist University.
Kenneth R. Peak Mr. Peak has served as a
director of Patterson-UTI since November 2000. Mr. Peak has
served as Chairman and Chief Executive Officer of Contango
Oil & Gas Company since September 1999. Mr. Peak
entered the energy industry in 1972 as a commercial banker and
has held a variety of financial and executive positions in the
oil and gas industry prior to starting Contango in 1999.
Mr. Peak served as an officer in the U.S. Navy from
1968 to 1971. Mr. Peak received a Bachelor of Science in
Physics from Ohio University in 1967 and a Masters of Business
Administration from Columbia University in 1972.
Cloyce A. Talbott Mr. Talbott has served
as a director of Patterson-UTI since its incorporation in 1978.
Mr. Talbott co-founded Patterson-UTI and has served in
various capacities, including as its Chief Executive Officer
from 1983 until his retirement from that position on
September 30, 2007. He also served as Chairman of the Board
from 1983 to May 2001. Mr. Talbott is currently employed as
a consultant by Patterson-UTI. Mr. Talbott holds a Bachelor
of Science degree in petroleum engineering from Texas Tech
University.
Meetings
and Committees of the Board of Directors
The Board of Directors met seven times during the year ended
December 31, 2008. Each director attended, in person or by
telephone, at least 75% of the aggregate of all meetings held by
the Board and meetings of each committee on which such director
served. A majority of the members of the Board of Directors are
independent within the meaning of the NASDAQ Stock Market, Inc.
(NASDAQ) listing standards. Specifically, the Board
has determined that Messrs. Buckner, Huff, Hunt and Peak
are independent within the meaning of the NASDAQ listing
standards. In reaching this conclusion, the Board considered
that Mr. Huff controls and manages two investment
companies, which have interests in oilfield service portfolio
companies that supply parts and equipment to Patterson-UTI in
the ordinary course of their businesses consistent with
customary terms in the industry. The Board has determined that
these transactions are not material to such companies,
Patterson-UTI or Mr. Huff and that such transactions do not
affect Mr. Huffs independence under applicable rules
and regulations.
The Board of Directors has established four standing committees,
an Executive Committee, an Audit Committee, a Compensation
Committee and a Nominating and Corporate Governance Committee.
The Executive Committee, which currently is composed of
Messrs. Siegel, Talbott and Berns, has the authority, to
the extent permitted by applicable law, to act for the Board in
all matters arising between regular or special meetings of the
Board of Directors.
The Audit Committee members are Messrs. Huff (chairman),
Buckner and Hunt, each of whom is independent within the meaning
of applicable Securities Exchange Act of 1934, as amended (the
Exchange Act), rules and within the meaning of the
NASDAQ listing standards. The Audit Committee oversees
managements conduct of Patterson-UTIs accounting and
financial reporting process, including review of the financial
reports and other
4
financial information provided by Patterson-UTI to the public
and government and regulatory bodies, Patterson-UTIs
system of internal accounting, Patterson-UTIs financial
controls, and the annual independent audit of
Patterson-UTIs financial statements. The Audit Committee
also oversees compliance with Patterson-UTIs codes of
conduct and ethics and with legal and regulatory requirements.
The Board has determined that Messrs. Huff and Buckner are
audit committee financial experts within the meaning
of applicable SEC rules. The Audit Committee selects the
independent registered public accounting firm to audit
Patterson-UTIs books and records and considers and acts
upon accounting matters as they arise. The Board of Directors
has adopted a written charter for the Audit Committee. The Audit
Committee held seven meetings during the year ended
December 31, 2008. Please see Audit Committee
Report elsewhere in this proxy statement.
The Compensation Committee members are Messrs. Peak
(chairman), Buckner and Huff, each of whom is independent as
defined in the NASDAQ listing standards. Among other things, the
Compensation Committee sets and administers the policies that
govern the compensation of executive officers and directors of
Patterson-UTI. The Board of Directors has adopted a written
charter for the Compensation Committee. The Compensation
Committee held four meetings during the year ended
December 31, 2008. Please see Compensation Discussion
and Analysis and Compensation Committee Report
elsewhere in this proxy statement for further information about
the Compensation Committee.
The Nominating and Corporate Governance Committee members are
Messrs. Hunt (chairman), Huff and Peak, each of whom is
independent as defined in the NASDAQ listing standards. The
purpose of the Nominating and Corporate Governance Committee is
to identify individuals qualified to become Board members, to
recommend for selection by the Board director nominees for the
next annual meeting of stockholders, to review
Patterson-UTIs Code of Business Conduct, to develop and
continually make recommendations with respect to the best
corporate governance principles and to oversee the evaluation of
the Board and management. The Board of Directors has adopted a
written charter for the Nominating and Corporate Governance
Committee. The Nominating and Corporate Governance Committee
held one meeting during the year ended December 31, 2008.
All of the director nominees are existing directors of
Patterson-UTI standing for re-election to the Board of Directors.
On behalf of the Board, the Nominating and Governance Committee
considers director nominees recommended by Patterson-UTIs
stockholders if the recommendations are made in accordance with
all legal requirements, including applicable provisions of
Patterson-UTIs restated certificate of incorporation and
bylaws. In accordance with Patterson-UTIs bylaws, in
addition to any other applicable requirements, nominations of
persons for election to the Board may be made at a meeting of
stockholders only by or at the direction of the Board or by a
stockholder who is a stockholder of record on the date of the
giving of the notice provided for below and on the record date
for the determination of stockholders entitled to vote at such
annual meeting and gives timely notice of such nomination in
writing to the Secretary of Patterson-UTI. To be timely with
respect to the 2010 annual meeting of stockholders, a
stockholders notice must be delivered to or mailed and
received at Patterson-UTIs principal executive offices not
earlier than February 3, 2010 and not later than
March 5, 2010; provided, however, that in the event that
the annual meeting is called for a date that is not within
30 days before or after June 3, 2010, notice by the
stockholder must be received not later than the close of
business on the tenth day following the day on which such notice
of the date of the meeting was mailed or public disclosure of
the annual meeting date was made, whichever occurs first.
A stockholders notice to the Secretary of Patterson-UTI
shall set forth:
|
|
|
|
|
as to each person whom the stockholder proposes to nominate for
election or re-election as director, all information relating to
such person that is required to be disclosed in solicitations of
proxies for election of directors, or is otherwise required, in
each case pursuant to Regulation 14A promulgated under the
Exchange Act, or any successor regulation thereto,
|
|
|
|
the name and record address of the stockholder proposing such
nomination,
|
|
|
|
the class and number of shares of Patterson-UTI that are
beneficially owned by the stockholder,
|
5
|
|
|
|
|
a description of all arrangements or understandings between such
stockholder and each proposed nominee and any other person or
persons (including their names) pursuant to which the nomination
or nominations are to be made by such stockholder, and
|
|
|
|
a representation that such stockholder intends to appear in
person or by proxy at the meeting to nominate the persons named
in the notice.
|
Such notice must be accompanied by a written consent of each
proposed nominee to being named as a nominee and to serve as a
director if elected.
The Nominating and Corporate Governance Committee determines
qualification criteria and procedures for the identification and
recruitment of candidates for election to serve as directors of
Patterson-UTI. The Nominating and Corporate Governance Committee
relies on the knowledge and relationships of Patterson-UTI and
its officers and directors, as well as third parties when it
deems appropriate, to identify and evaluate nominees for
director, including nominees recommended by stockholders.
Communication
with the Board and its Independent Members
Persons may communicate with the Board, or directly with its
Chairman, Mr. Siegel, by submitting such communication in
writing in care of Chairman of the Board of Directors,
Patterson-UTI Energy, Inc., 450 Gears Road, Suite 500,
Houston, Texas 77067. Persons may communicate with the
independent members of the Board by submitting such
communication in writing to the Nominating and Corporate
Governance Committee of the Board of Directors of Patterson-UTI
Energy, Inc., 450 Gears Road, Suite 500, Houston, Texas
77067.
Although Patterson-UTI does not have a formal policy regarding
attendance by members of the Board at its annual meetings of
stockholders, directors are invited to attend annual meetings of
Patterson-UTI stockholders. All directors attended the 2008
annual meeting of stockholders with one director attending in
person and the remaining directors attending via telephone.
Corporate
Governance Documents Available on Patterson-UTIs
Website
Copies of each of the following documents can be accessed
electronically in the Governance section of the
Patterson-UTI website at www.patenergy.com and in print
to any stockholder who requests them from the Secretary of
Patterson-UTI:
|
|
|
|
|
Audit Committee Charter;
|
|
|
|
Compensation Committee Charter;
|
|
|
|
Nominating and Corporate Governance Committee Charter;
|
|
|
|
Code of Business Conduct for its employees, officers and
directors; and
|
|
|
|
Code of Business Conduct and Ethics for Senior Financial
Executives.
|
PROPOSAL NO. 2
RATIFICATION
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee appointed PricewaterhouseCoopers LLP as
independent registered public accounting firm to audit the
financial statements of Patterson-UTI for the fiscal year ending
December 31, 2009, and directed that such engagement be
submitted to the stockholders of Patterson-UTI for ratification.
In recommending ratification by the stockholders of such
engagement, the Board of Directors is acting upon the
recommendation of the Audit Committee, which has satisfied
itself as to PricewaterhouseCoopers LLPs independence,
professional competence and standing. Although ratification by
stockholders of the engagement of PricewaterhouseCoopers LLP is
not required by Delaware corporate law or Patterson-UTIs
restated certificate of incorporation or bylaws, the Audit
Committee believes a decision of this nature should be made with
the consideration of Patterson-UTIs stockholders. If the
stockholders fail to ratify the appointment, the Audit Committee
will reconsider whether to retain PricewaterhouseCoopers LLP and
may retain that firm or another without re-submitting the matter
to our
6
stockholders. Even if the appointment is ratified, the Audit
Committee may, in its discretion, direct the appointment of a
different independent registered public accounting firm at any
time during the year if it determines that such change would be
in the best interests of Patterson-UTI and its stockholders.
It is expected that one or more representatives of
PricewaterhouseCoopers LLP will be present at the Meeting and
will be given the opportunity to make a statement if they so
desire. It also is expected that the representative(s) will be
available to respond to appropriate questions from the
stockholders.
The Board of Directors recommends a vote FOR the
ratification of PricewaterhouseCoopers LLP as
Patterson-UTIs independent registered public accounting
firm. Ratification of the selection of
PricewaterhouseCoopers LLP requires the affirmative vote of the
holders of a majority of the shares of Common Stock present in
person or by proxy, and entitled to vote at the Meeting. Unless
you give contrary instructions in your proxy, your proxy will be
voted FOR such ratification. Abstentions will be
counted as shares entitled to vote on the proposal and will have
the same effect as a vote AGAINST the proposal. A
broker non-vote will be counted for purposes of establishing a
quorum, but will not be treated as a share entitled to vote on
the proposal.
EXECUTIVE
OFFICERS
Set forth below is the name, age and position followed by a
brief description of the business experience during at least the
past five years for each executive officer of Patterson-UTI who
is not also a member of the Board of Directors.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Douglas J. Wall
|
|
|
56
|
|
|
President and Chief Executive Officer
|
John E. Vollmer III
|
|
|
53
|
|
|
Senior Vice President Corporate Development, Chief
Financial Officer and Treasurer
|
William L. Moll, Jr.
|
|
|
42
|
|
|
General Counsel and Secretary
|
Gregory W. Pipkin
|
|
|
37
|
|
|
Chief Accounting Officer and Assistant Secretary
|
Douglas J. Wall Mr. Wall has served as
President and Chief Executive Officer of Patterson-UTI since
October 1, 2007. From April through September 2007 he
served as Chief Operating Officer of Patterson-UTI. From 2005 to
April 2007, Mr. Wall served as Group President, Completion
and Production of Baker Hughes Incorporated, an oilfield service
company. In that capacity, Mr. Wall was responsible for the
combined activities of Baker Oil Tools, Baker Petrolite,
Centrilift and ProductionQuest divisions. From 2003 to 2005 he
served as President of Baker Oil Tools, a division of Baker
Hughes, and from 1997 to 2003 he served as President of Hughes
Christensen Company, a division of Baker Hughes. Mr. Wall
holds a Bachelor Degree in Economics from the University of
Calgary and a Masters of Business Administration in Finance and
Marketing from the University of Alberta.
John E. Vollmer III Mr. Vollmer has
served as Chief Financial Officer and Treasurer of Patterson-UTI
since November 2005 and Senior Vice President
Corporate Development of Patterson-UTI since May 2001.
Mr. Vollmer also served as Secretary of Patterson-UTI from
November 2005 to February 2007. Mr. Vollmer served as
Senior Vice President, Chief Financial Officer, Secretary and
Treasurer of UTI from 1998 to May 2001. From 1992 until 1997,
Mr. Vollmer served in a variety of capacities at
Blockbuster Entertainment, including Senior Vice
President Finance and Chief Financial Officer of
Blockbuster Entertainments Music Division.
Mr. Vollmer holds a Bachelor of Arts in Accounting from
Michigan State University.
William L. Moll, Jr. Mr. Moll has
served as General Counsel and Secretary of Patterson-UTI since
February 2007. From July 2006 to February 2007, Mr. Moll
served as Vice President and Counsel of Stewart &
Stevenson LLC, an oilfield equipment manufacturing company. From
January 1996 to July 2006, Mr. Moll served in a variety of
capacities in the legal department of Stewart &
Stevenson Services, Inc., an equipment manufacturing company,
including Deputy General Counsel from March 2005 to July 2006
and Managing Attorney from September 2001 to March 2005. From
September 1991 to January 1996, Mr. Moll was an associate
with the law firm of Andrews & Kurth LLP.
Mr. Moll holds a Bachelor of Business Administration in
Accounting from the University of Texas and a J.D. from the
University of Houston Law Center.
7
Gregory W. Pipkin Mr. Pipkin has served
as Chief Accounting Officer and Assistant Secretary of
Patterson-UTI
since August 2007. From June 2006 to August 2007,
Mr. Pipkin served as Director of Financial Reporting of
Patterson-UTI. From April 2001 through May 2006, Mr. Pipkin
was Controller and Vice President of Accounting and Reporting
for Alamosa Holdings, Inc., a publicly traded wireless
telecommunications company. Prior to April 2001, Mr. Pipkin
was in the practice of public accounting. Mr. Pipkin is a
Certified Public Accountant and holds a Bachelor of Business
Administration in Accounting from Texas Tech University.
COMPENSATION
DISCUSSION AND ANALYSIS
Overview
Compensation
Committee
The Compensation Committee (the Committee) sets and
administers the policies that govern the compensation of
executive officers and directors of Patterson-UTI. As part of
its duties, the Committee determines the compensation of
Patterson-UTIs executive officers who are named in the
Summary Compensation Table appearing elsewhere in this proxy
statement (the Named Executive Officers) and grants
all awards of restricted stock and stock options under
Patterson-UTIs long-term incentive plan.
The Committee currently consists of Messrs. Peak
(chairman), Buckner and Huff, each of whom is an independent
director as defined by the NASDAQ listing standards.
Compensation
Objectives
The Committees objectives are to provide to the Named
Executive Officers competitive compensation packages that will
permit Patterson-UTI to attract and retain highly qualified
individuals and to motivate and reward the Named Executive
Officers for performance that benefits Patterson-UTI and its
stockholders.
Role
of Management and Compensation Consultant
All compensation decisions with respect to the Named Executive
Officers of Patterson-UTI are made solely by the Committee. The
Committee is permitted under its charter to delegate any of its
powers to a subcommittee of the Committee. In performing its
duties, the Committee considers input from senior management on
individual performance and compensation matters.
In determining compensation for the Named Executive Officers for
2008, the Committee considered a variety of information,
including (1) compensation for executive officers at
similarly situated oilfield service companies,
(2) historical and projected financial and operational
results at Patterson-UTI, including margins achieved, rig
utilization, net income and earnings before interest, taxes,
depreciation and amortization (EBITDA) and return on
equity and assets, (3) historical stock performance,
(4) operational and strategic objectives of Patterson-UTI
and (5) individual performance.
For 2008, the Committee engaged Towers Perrin, an independent
compensation consultant, who reported directly to the Committee
to evaluate and make recommendations to the Committee regarding
Patterson-UTIs executive compensation philosophy and
practices. Towers Perrin reviewed the executive salaries,
non-equity incentive compensation and long-term incentives for
competitiveness with similarly situated oilfield service
companies. Towers Perrin was provided a proposed representative
peer group within the oilfield services industry based on
various criteria and was provided information as to the
responsibilities of the members of Patterson-UTIs
executive team in relationship to its peers. Towers Perrin also
analyzed Patterson-UTIs share utilization as compared to
its peers for purposes of assessing dilution resulting from
awards under Patterson-UTIs incentive plans. Towers Perrin
was asked to provide its advice as to Patterson-UTIs
incentive plans and the Committees proposed compensation
of the Named Executive Officers and the reasonableness of that
compensation.
For 2008, the Committee reviewed compensation data from the
following peer group of companies: BJ Services Company, Cameron
International Corporation, Diamond Offshore Drilling Inc., Ensco
International Inc., FMC Technologies Inc., Helmerich &
Payne Inc., Nabors Industries Ltd., National Oilwell Varco Inc.,
Noble Corp.,
8
Pride International, Inc., Rowan Companies Inc., Smith
International Inc., Transocean Inc. and Weatherford
International Ltd.
Elements
of Compensation
Patterson-UTIs compensation program for its Named
Executive Officers includes three primary elements:
(1) base salary, (2) non-equity incentive compensation
in the form of cash bonuses and (3) long-term incentive
opportunities in the form of restricted stock and stock options.
Below is a summary of each element of compensation. The general
intent of the base salary for the Named Executive Officers was
for that compensation to be around the 50th percentile of
the peer group and for incentive and equity based compensation
to be above the 75th percentile. These objectives were
established based on Patterson-UTIs historical top tier
performance on returns on assets and equity and long-term share
value creation as compared to peers.
Base
Salary
Historically, the Committee has emphasized performance-based
compensation in the form of non-equity and equity incentive
compensation and has minimized salary adjustments. From 2004
through 2006 there were no increases to the base salaries of the
Named Executive Officers. In February 2007, the base salary of
Mr. Berns was increased from $215,000 to $265,000. In
October 2007, upon being named President and Chief Executive
officer of Patterson-UTI, Mr. Walls base salary was
increased from $450,000 to $600,000. In February 2008, the base
salary of Mr. Vollmer was increased from $275,000 to
$350,000.
The base salaries of Named Executive Officers are reviewed and
determined annually by the Committee based on
(i) subjective evaluations of the officers functional
position and specific performance, (ii) assessment of the
relative importance of each position at Patterson-UTI,
(iii) a comparison to salary ranges for executives of other
companies in the oilfield service industry with market,
financial and operational characteristics similar to those of
Patterson-UTI, (iv) Patterson-UTIs financial results
and position and (v) Patterson-UTIs performance
compared to similarly situated companies.
Non-Equity
Incentive Compensation
The Named Executive Officers have historically received
non-equity incentive compensation in the form of annual cash
bonuses designed to put a meaningful portion of total
compensation at risk. In 2008, non-equity incentive compensation
for Messrs. Siegel, Wall, Vollmer and Berns was tied to a
bonus pool based upon Patterson-UTIs EBITDA. The bonus
pool was allocated among the four officers pursuant to a
pre-determined sharing percentage that reflected a team-based
philosophy as well as the organizational structure of the top
management team. The bonus pool and allocation are subject to
modification by the Committee at its discretion. EBITDA has been
chosen as the performance measure for the annual cash bonus
because Patterson-UTI believes it is an important measure of
current year financial performance. Non-equity incentive
compensation for Mr. Moll during 2008 was determined at the
discretion of the Committee based on the operating performance
of the Company and the individual performance of Mr. Moll.
In 2008, the bonus pool for Messrs. Siegel, Wall, Vollmer
and Berns, subject to a minimum threshold of $400 million
of EBITDA, was approximately 0.611 of one percent of
Patterson-UTIs EBITDA. The allocation of the bonus pool as
a percentage of 2008 EBITDA was as follows: 0.222 of one percent
to Mr. Siegel, 0.167 of one percent to Mr. Wall and
0.111 of one percent to each of Messrs. Vollmer and Berns.
While, the Committee did not establish a specific threshold
bonus amount for each such officer; the Grants of Plan-Based
Awards table presents a threshold bonus amount for each such
officer based on an assumed EBITDA at the minimum EBITDA
threshold of $400 million and the allocation formula. The
maximum amount that can be awarded to an individual under any
cash-based performance award granted under the 2005 Plan during
a 12-month
period is $5,000,000. In order to reach this maximum amount,
EBITDA of $2.25 billion in the case of Mr. Siegel,
$3.00 billion in the case of Mr. Wall and
$4.50 billion in the case of Messrs. Vollmer and Berns
would have been needed. The Committee did not establish a target
bonus amount. The target bonus amount presented in the Grants of
Plan-Based Awards table is calculated for the respective officer
based on Patterson-UTIs actual EBITDA for the fiscal year
ended December 31, 2008 and the allocation formula applied
to the bonus pool for distribution.
9
The aggregate bonus pool paid to Messrs. Siegel, Wall,
Vollmer and Berns for 2008 was $5,013,720 based on
Patterson-UTIs 2008 EBITDA of $820,427,000. Based on the
target allocation above, Mr. Siegel received $1,823,171;
Mr. Wall received $1,367,378 and Messrs. Vollmer and
Berns each received $911,586. Consistent with
Patterson-UTIs emphasis on performance-based compensation,
non-equity incentive compensation for 2008 represented a
significant portion of each Named Executive Officers total
cash compensation from Patterson-UTI for the year.
The Committee has established a target bonus pool for 2009 for
Messrs. Siegel, Wall, Vollmer and Berns, subject to a
minimum EBITDA threshold of $200 million, of approximately
0.611 of one percent of Patterson-UTIs EBITDA. The target
allocation of the bonus pool as a percentage of 2009 EBITDA, is
as follows: 0.222 of one percent to Mr. Siegel, 0.167 of
one percent to Mr. Wall and 0.111 of one percent to each of
Messrs. Vollmer and Berns.
Long-Term
Incentive Compensation
Long-term incentive compensation for the Named Executive
Officers consists of both awards of shares of restricted stock
and options to purchase Common Stock, each of which vest over
three or four years. Awards of such equity-based compensation
reflect the Committees desire to provide the Named
Executive Officers with additional incentives by increasing
their proprietary interest in the success of Patterson-UTI. The
Committee believes that there should be an emphasis on
equity-based compensation in order to provide incentives and
rewards that are closely aligned with stockholders. The
Committee reviews equity-based compensation of the Named
Executive Officers on an annual basis.
Patterson-UTIs equity-based compensation has historically
been given significant weight, along with non-equity incentive
compensation, in the overall compensation package of the Named
Executive Officers. The allocation of equity-based compensation
among the Named Executive Officers is made by the Committee
based on various factors, including the executives
position and contribution to the overall goals and objectives of
Patterson-UTI.
The allocation and mix of equity-based compensation between
restricted stock and stock options in 2008 followed this
approach, with an emphasis on stock options over restricted
stock for the four most highly compensated Named Executive
Officers in order to ensure that the greatest awards would only
be earned for increases in Patterson-UTIs equity value.
The Committees practice has generally been to grant stock
options
and/or
restricted stock to Named Executive Officers at a meeting
following the conclusion of Patterson-UTIs first quarter.
Such meetings are typically held in conjunction with regular
quarterly Board meetings that are held prior to
Patterson-UTIs public release of quarterly earnings
information. Options are granted at an exercise price equal to
the closing price of Patterson-UTIs stock on the date of
grant.
Retirement
Plans
Patterson-UTI offers a 401(k) plan to its employees, including
its Named Executive Officers. Participants may contribute a
portion of their base salary to the 401(k) plan, subject to
federal limits. Patterson-UTI makes matching contributions up to
four percent of each participants eligible base salary.
The Named Executive Officers of Patterson-UTI are eligible to
participate in the 401(k) plan on the same basis as other
employees. Patterson-UTI does not have any other retirement plan.
Perquisites
and Personal Benefits
No Named Executive Officer received perquisites totaling more
than $10,000. Accordingly, the perquisites do not meet the
threshold which would require disclosure in the Summary
Compensation Table below.
Share
Ownership Guidelines
The Committee in 2004, with the approval of the Board, enacted
share ownership guidelines applicable to all executive officers
and directors of Patterson-UTI. Under these guidelines and
subject to a four-year phase-in, each of Patterson-UTIs
Chairman, Chief Executive Officer and President was required to
hold shares of Common Stock
10
having a value equal to at least five times the officers
base salary and each of Patterson-UTIs other executive
officers was required to hold shares of Common Stock having a
value equal to at least three times the officers base
salary. The Committee also enacted share ownership guidelines
for directors. Under those guidelines, subject to a four-year
phase-in, each director of Patterson-UTI was required to hold
shares of Common Stock having a value equal to at least four
times the annual base retainer provided to the director. Each of
the Named Executive Officers and Directors was in compliance
with these guidelines as of December 31, 2008.
In April 2009, in response to significant volatility in the
market price of the Common Stock, the Nominating and Corporate
Governance Committee modified the share ownership guidelines.
The modified guidelines require the holding of a minimum number
of shares of Common Stock rather than a specified dollar value
of Common Stock. The modified guidelines require officers and
directors to hold at all times, subject to a four year phase-in
from the date first elected as an officer or director, at least
the following number of shares of Common Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
Chairman
|
|
|
120,000 shares
|
|
|
|
|
|
President and Chief Executive Officer
|
|
|
90,000 shares
|
|
|
|
|
|
Senior Vice Presidents
|
|
|
60,000 shares
|
|
|
|
|
|
General Counsel
|
|
|
7,500 shares
|
|
|
|
|
|
Chief Accounting Officer
|
|
|
7,500 shares
|
|
|
|
|
|
Outside Directors
|
|
|
10,000 shares
|
|
|
|
|
|
Non-executive Inside Director
|
|
|
10,000 shares
|
|
Each of the Named Executive Officers and Directors is in
compliance with the modified guidelines as of the date of this
proxy statement.
Change in
Control and Severance Agreements
Patterson-UTI has entered into change in control agreements with
its Named Executive Officers as further described elsewhere in
this proxy statement. The Committee believes that the change in
control agreements help Patterson-UTI to attract and retain the
Named Executive Officers by reducing the personal uncertainty
and anxiety that arises from the possibility of a future
business combination. The Committee also believes the change in
control agreements should prevent the Named Executive Officers
from leaving employment out of concern for the security of their
jobs or being unable to concentrate on their work.
Patterson-UTI has entered into written letter agreements with
each of Messrs. Siegel, Berns and Vollmer pursuant to which
Patterson-UTI has agreed to pay each such person within ten days
of the termination of his employment with Patterson-UTI for any
reason (including voluntary termination by him), an amount in
cash equal to his annual base salary at the time of such
termination. Patterson-UTI has entered into a severance
agreement with Mr. Wall that generally has a three-year
term and provides for a lump-sum cash payment of $750,000 to be
payable to Mr. Wall within ten days of the date of a
qualifying termination of his employment with Patterson-UTI. A
qualifying termination for Mr. Wall is defined in the
severance agreement generally as a termination by Patterson-UTI
for any reason other than cause or, if certain conditions are
met, a termination by Mr. Wall due to a reduction in his
annual base salary below a defined threshold amount. Any payment
made by Patterson-UTI pursuant to these letter agreements or the
severance agreement will reduce dollar for dollar any payment
owed to such person, if any, pursuant to the change in control
agreements discussed above.
Section 162(m)
Considerations
In considering compensation decisions for the executive
management of Patterson-UTI, the Committee routinely considers
the potential effect of Section 162(m) of the Internal
Revenue Code. Section 162(m) imposes a limitation on
corporate tax deductions for non-performance based compensation
to certain officers that exceeds $1 million that can be
taken by a publicly held corporation for compensation paid to
certain of its executive officers. The Committee believes that
tax deduction limitations should not compromise
Patterson-UTIs ability to establish and maintain
appropriate executive compensation programs and reserves the
right to award non-deductible compensation.
11
COMPENSATION
COMMITTEE REPORT
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis included in this proxy
statement required by Item 402(b) of
Regulation S-K
with management and, based upon such review and discussion, the
Compensation Committee has recommended to the Board that the
Compensation Discussion and Analysis be included in this proxy
statement.
Kenneth R. Peak, Chairman
Charles O. Buckner
Curtis W. Huff
The following table sets forth information concerning
compensation for the fiscal year ended December 31, 2008
with respect to the Principal Executive Officer, the Principal
Financial Officer and the other Named Executive Officers of
Patterson-UTI:
Summary
Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Incentive plan
|
|
All Other
|
|
|
|
|
|
|
Salary
|
|
Bonus
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Compensation
|
|
Total
|
Name and Principal Position(s)
|
|
Year
|
|
($)
|
|
($)
|
|
($)(1)
|
|
($)(2)
|
|
($)(3)
|
|
($)(4)
|
|
($)
|
|
Douglas J. Wall
|
|
|
2008
|
|
|
$
|
600,000
|
|
|
$
|
|
|
|
$
|
1,314,966
|
|
|
$
|
554,820
|
|
|
$
|
1,367,378
|
|
|
$
|
9,200
|
|
|
$
|
3,846,364
|
|
President & Chief
Executive Officer
|
|
|
2007
|
|
|
$
|
365,625
|
|
|
$
|
1,075,000
|
(5)
|
|
$
|
1,015,694
|
|
|
$
|
135,444
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2,591,763
|
|
John E. Vollmer III
|
|
|
2008
|
|
|
$
|
326,125
|
|
|
$
|
|
|
|
$
|
724,222
|
|
|
$
|
987,847
|
|
|
$
|
911,586
|
|
|
$
|
9,200
|
|
|
$
|
2,958,980
|
|
Senior Vice President
|
|
|
2007
|
|
|
$
|
275,000
|
|
|
$
|
|
|
|
$
|
549,034
|
|
|
$
|
808,411
|
|
|
$
|
1,022,050
|
|
|
$
|
10,735
|
|
|
$
|
2,665,230
|
|
Corporate Development, Chief
Financial Officer & Treasurer
|
|
|
2006
|
|
|
$
|
275,000
|
|
|
$
|
|
|
|
$
|
298,959
|
|
|
$
|
759,341
|
|
|
$
|
1,375,000
|
|
|
$
|
6,641
|
|
|
$
|
2,714,941
|
|
Mark S. Siegel
|
|
|
2008
|
|
|
$
|
350,000
|
|
|
$
|
|
|
|
$
|
1,448,444
|
|
|
$
|
1,975,694
|
|
|
$
|
1,823,171
|
|
|
$
|
|
|
|
$
|
5,597,309
|
|
Chairman of the Board
|
|
|
2007
|
|
|
$
|
350,000
|
|
|
$
|
|
|
|
$
|
1,098,069
|
|
|
$
|
1,616,823
|
|
|
$
|
2,044,100
|
|
|
$
|
|
|
|
$
|
5,108,992
|
|
|
|
|
2006
|
|
|
$
|
350,000
|
|
|
$
|
|
|
|
$
|
597,918
|
|
|
$
|
1,398,886
|
|
|
$
|
2,750,000
|
|
|
$
|
|
|
|
$
|
5,096,804
|
|
Kenneth N. Berns
|
|
|
2008
|
|
|
$
|
265,000
|
|
|
$
|
|
|
|
$
|
724,222
|
|
|
$
|
987,847
|
|
|
$
|
911,586
|
|
|
$
|
|
|
|
$
|
2,888,655
|
|
Senior Vice President
|
|
|
2007
|
|
|
$
|
258,055
|
|
|
$
|
|
|
|
$
|
549,034
|
|
|
$
|
808,411
|
|
|
$
|
1,022,050
|
|
|
$
|
|
|
|
$
|
2,637,550
|
|
|
|
|
2006
|
|
|
$
|
215,000
|
|
|
$
|
|
|
|
$
|
298,959
|
|
|
$
|
699,443
|
|
|
$
|
1,375,000
|
|
|
$
|
|
|
|
$
|
2,588,402
|
|
William L. Moll, Jr.
|
|
|
2008
|
|
|
$
|
250,000
|
|
|
$
|
50,000
|
|
|
$
|
171,587
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
471,587
|
|
General Counsel and Secretary
|
|
|
2007
|
|
|
$
|
222,538
|
|
|
$
|
100,000
|
|
|
$
|
251,261
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
573,799
|
|
|
|
|
(1) |
|
Amounts set forth represent the dollar amount of compensation
expense recognized for financial statement reporting purposes
for the fiscal years ended December 31, 2008, 2007 and 2006
in accordance with Statement of Financial Accounting Standards
No. 123(R) (FAS 123R) with respect to
restricted stock held by the Named Executive Officer. For
additional information related to the assumptions used and
valuation of restricted stock, see Note 10 to the
consolidated financial statements in Patterson-UTIs Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2008. |
|
(2) |
|
Amounts set forth represent the dollar amount of compensation
expense recognized for financial statement reporting purposes
for the fiscal years ended December 31, 2008, 2007 and 2006
in accordance with FAS 123R with respect to stock options
held by the Named Executive Officer. For additional information
related to the assumptions used in connection with the valuation
of stock options using the Black-Scholes option pricing model
see Note 10 to the consolidated financial statements in
Patterson-UTIs Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008. |
|
(3) |
|
Represents annual bonuses earned for the fiscal years ended
December 31, 2008, 2007 and 2006. The bonus plan in each of
those fiscal years provided for a bonus pool based on EBITDA,
subject to a minimum EBITDA of $400 million. The bonus pool
was allocated among the participants based on a pre-determined
sharing percentage. At the direction of the Compensation
Committee, the total amount paid out pursuant to the executive
bonus pool was $5.01 million for 2008, $6.13 million
for 2007 and $8.25 million for 2006. |
|
(4) |
|
Amounts set forth reflect contributions to a 401(k) plan by
Patterson-UTI on behalf of the Named Executive Officer. |
12
|
|
|
(5) |
|
Amount includes a signing bonus of $275,000 paid to
Mr. Wall following the commencement of his employment with
Patterson-UTI and an annual bonus for the fiscal year ended
December 31, 2007 of $800,000, which was paid pursuant to
the terms of the offer letter provided to Mr. Wall prior to
his employment with Patterson-UTI. |
The following table sets forth information concerning grants of
plan-based awards during the fiscal year ended December 31,
2008 to the Named Executive Officers:
Grants of
Plan-Based Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All other
|
|
|
Option Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards:
|
|
|
Number of
|
|
|
Exercise or
|
|
|
Grant Date
|
|
|
|
|
|
|
Estimated Possible Payouts under
|
|
|
Number of
|
|
|
Securities
|
|
|
Base Price
|
|
|
Fair Value of
|
|
|
|
|
|
|
Non-equity Incentive Plan Awards(1)
|
|
|
Shares of
|
|
|
Underlying
|
|
|
of Option
|
|
|
Stock and
|
|
|
|
Grant
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Stock or Units
|
|
|
Options
|
|
|
Awards
|
|
|
Option Awards
|
|
Name
|
|
Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)(2)
|
|
|
(#)(3)
|
|
|
($/Sh)
|
|
|
($)(4)
|
|
|
Douglas J. Wall
|
|
|
2/11/08
|
|
|
$
|
666,667
|
|
|
$
|
1,367,378
|
|
|
$
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71,250
|
|
|
|
|
|
|
|
|
|
|
$
|
2,088,338
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178,500
|
|
|
$
|
29.31
|
|
|
$
|
1,458,584
|
|
John E. Vollmer III
|
|
|
2/11/08
|
|
|
$
|
444,444
|
|
|
$
|
911,586
|
|
|
$
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,500
|
|
|
|
|
|
|
|
|
|
|
$
|
1,392,225
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
119,000
|
|
|
$
|
29.31
|
|
|
$
|
972,389
|
|
Mark S. Siegel
|
|
|
2/11/08
|
|
|
$
|
888,889
|
|
|
$
|
1,823,171
|
|
|
$
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95,000
|
|
|
|
|
|
|
|
|
|
|
$
|
2,784,450
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
238,000
|
|
|
$
|
29.31
|
|
|
$
|
1,944,779
|
|
Kenneth N. Berns
|
|
|
2/11/08
|
|
|
$
|
444,444
|
|
|
$
|
911,586
|
|
|
$
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,500
|
|
|
|
|
|
|
|
|
|
|
$
|
1,392,225
|
|
|
|
|
4/25/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
119,000
|
|
|
$
|
29.31
|
|
|
$
|
972,389
|
|
William L. Moll, Jr.
|
|
|
6/4/08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
$
|
126,400
|
|
|
|
|
(1) |
|
For the fiscal year ended December 31, 2008, the bonus plan
for Messrs. Wall, Vollmer, Siegel and Berns provided for a
bonus pool based on EBITDA, subject to a minimum EBITDA of
$400 million. The bonus pool was allocated among
Messrs. Wall, Vollmer, Siegel and Berns based on a
pre-determined sharing percentage. The threshold amount
presented in this table is calculated for the respective officer
based on an assumed EBITDA of $400 million and the
allocation formula applied to the bonus pool for distribution
due to the fact that the bonus plan provides for no payment if
the minimum EBITDA of $400 million is not satisfied. The
target amount is calculated based on Patterson-UTIs actual
EBITDA for the fiscal year ended December 31, 2008 and the
allocation formula applied to the bonus pool for distribution.
The cash bonuses awarded from the bonus pool were awarded under
the 2005 Plan, which has been designed to meet the requirements
of Section 162(m) of the Code. Although the bonus pool for
Messrs. Wall, Vollmer, Siegel and Berns did not have an
EBITDA cap, the maximum amount that could be awarded to an
individual under any cash-based performance award granted under
the 2005 Plan during a
12-month
period is $5,000,000. |
|
(2) |
|
Shares of restricted stock were awarded pursuant to the 2005
Plan. Ordinary dividends are paid on unvested shares of
restricted stock. The rate at which these dividends are paid is
the same rate at which ordinary dividends are paid on all other
shares of common stock of Patterson-UTI. The right to receive
these dividends has been included in the grant date fair value
of stock awards presented in the table. The shares awarded to
Messrs. Wall, Vollmer, Siegel and Berns vest over a three
year period as follows: one-third on April 25, 2009, and
the remaining two-thirds in equal monthly installments over the
twenty-four months following April 25, 2009. The shares
awarded to Mr. Moll vest over a three year period as
follows: one-third on June 9, 2009, one-third on
June 9, 2010 and one-third on June 9, 2011. |
|
(3) |
|
Options were granted pursuant to the 2005 Plan. Those options
vest over a three year period as follows: one-third on
April 25, 2009, and the remaining two-thirds in equal
monthly installments over the twenty-four months following
April 25, 2009. |
|
(4) |
|
The grant date fair value of restricted stock is based on the
closing price of Patterson-UTI Common Stock on the date of
grant, which is consistent with the valuation used by
Patterson-UTI for the recognition of compensation expense under
FAS 123R. The grant date fair value of stock options was
determined using the Black-Scholes option pricing model, which
is consistent with the valuation used by Patterson-UTI for the
recognition of |
13
|
|
|
|
|
compensation expense under FAS 123R, with assumptions that
are more fully described in Note 10 to the consolidated
financial statements in Patterson-UTIs Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008. |
The following table sets forth information concerning
outstanding equity awards at December 31, 2008 for the
Named Executive Officers:
Outstanding
Equity Awards
at Fiscal Year-End
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of Securities
|
|
|
Option
|
|
|
|
|
|
Number of Shares
|
|
|
Market Value of
|
|
|
|
Underlying Unexercised
|
|
|
Exercise
|
|
|
Option
|
|
|
or Units of Stock
|
|
|
Shares or Units of
|
|
|
|
Options (#)
|
|
|
Price
|
|
|
Expiration
|
|
|
That Have
|
|
|
Stock That Have
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
($)
|
|
|
Date
|
|
|
Not Vested (#)
|
|
|
Not Vested ($)(1)
|
|
|
Douglas J. Wall
|
|
|
41,667
|
|
|
|
33,333
|
(2)
|
|
$
|
22.720
|
|
|
|
4/08/17
|
|
|
|
137,917
|
(3)
|
|
$
|
1,587,425
|
|
|
|
|
9,723
|
|
|
|
15,277
|
(4)
|
|
$
|
22.990
|
|
|
|
9/30/17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178,500
|
(5)
|
|
$
|
29.310
|
|
|
|
4/24/18
|
|
|
|
|
|
|
|
|
|
John E. Vollmer III
|
|
|
210,000
|
|
|
|
|
|
|
$
|
13.195
|
|
|
|
7/17/12
|
|
|
|
81,115
|
(6)
|
|
$
|
933,634
|
|
|
|
|
190,000
|
|
|
|
|
|
|
$
|
16.220
|
|
|
|
4/29/13
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
|
|
|
|
|
$
|
19.140
|
|
|
|
4/27/14
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
$
|
24.630
|
|
|
|
4/26/15
|
|
|
|
|
|
|
|
|
|
|
|
|
97,222
|
|
|
|
27,778
|
(7)
|
|
$
|
28.160
|
|
|
|
7/31/16
|
|
|
|
|
|
|
|
|
|
|
|
|
83,333
|
|
|
|
66,667
|
(8)
|
|
$
|
24.170
|
|
|
|
4/22/17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
119,000
|
(5)
|
|
$
|
29.310
|
|
|
|
4/24/18
|
|
|
|
|
|
|
|
|
|
Mark S. Siegel
|
|
|
380,000
|
|
|
|
|
|
|
$
|
16.220
|
|
|
|
4/29/13
|
|
|
|
162,230
|
(9)
|
|
$
|
1,867,267
|
|
|
|
|
120,000
|
|
|
|
|
|
|
$
|
19.140
|
|
|
|
4/27/14
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000
|
|
|
|
|
|
|
$
|
24.630
|
|
|
|
4/26/15
|
|
|
|
|
|
|
|
|
|
|
|
|
194,444
|
|
|
|
55,556
|
(7)
|
|
$
|
28.160
|
|
|
|
7/31/16
|
|
|
|
|
|
|
|
|
|
|
|
|
166,666
|
|
|
|
133,334
|
(8)
|
|
$
|
24.170
|
|
|
|
4/22/17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
238,000
|
(5)
|
|
$
|
29.310
|
|
|
|
4/24/18
|
|
|
|
|
|
|
|
|
|
Kenneth N. Berns
|
|
|
190,000
|
|
|
|
|
|
|
$
|
16.220
|
|
|
|
4/29/13
|
|
|
|
81,115
|
(6)
|
|
$
|
933,634
|
|
|
|
|
60,000
|
|
|
|
|
|
|
$
|
19.140
|
|
|
|
4/27/14
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
$
|
24.630
|
|
|
|
4/26/15
|
|
|
|
|
|
|
|
|
|
|
|
|
97,222
|
|
|
|
27,778
|
(7)
|
|
$
|
28.160
|
|
|
|
7/31/16
|
|
|
|
|
|
|
|
|
|
|
|
|
83,333
|
|
|
|
66,667
|
(8)
|
|
$
|
24.170
|
|
|
|
4/22/17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
119,000
|
(5)
|
|
$
|
29.310
|
|
|
|
4/24/18
|
|
|
|
|
|
|
|
|
|
William L. Moll, Jr.
|
|
|
|
|
|
|
|
|
|
$
|
|
|
|
|
|
|
|
|
17,334
|
(10)
|
|
$
|
199,514
|
|
|
|
|
(1) |
|
Based on the closing price of Patterson-UTI Common Stock on
December 31, 2008 of $11.51 per share. |
|
(2) |
|
These options vest in equal monthly installments from
January 9, 2009 through April 9, 2010. |
|
(3) |
|
These shares of restricted stock vest as follows:
33,333 shares on April 9, 2009, 23,750 shares on
April 25, 2009, 33,334 shares on April 9, 2010
and 47,500 shares that vest in equal monthly installments
from May 25, 2009 through April 25, 2011. |
|
(4) |
|
These options vest in equal monthly installments from
January 1, 2009 through October 1, 2010. |
|
(5) |
|
These options vest as follows: one-third on April 25, 2009,
and the remainder in equal monthly installments over the
twenty-four months following April 25, 2009. |
|
(6) |
|
These shares of restricted stock vest as follows:
11,115 shares in equal monthly installments from
January 23, 2009 through April 23, 2010;
15,833 shares on April 25, 2009; 7,500 shares on
April 27, 2009; 31,667 shares in equal monthly
installments from May 25, 2009 through April 25, 2011;
7,500 shares on August 1, 2009; 7,500 shares on
August 1, 2010. |
|
(7) |
|
These options vest in equal monthly installments from
January 1, 2009 through August 1, 2009. |
|
(8) |
|
These options vest in equal monthly installments from
January 23, 2009 through April 23, 2010. |
|
(9) |
|
These shares of restricted stock vest as follows:
22,230 shares in equal monthly installments from
January 23, 2009 through April 23, 2010;
31,666 shares on April 25, 2009; 15,000 shares on
April 27, 2009; 63,334 shares |
14
|
|
|
|
|
in equal monthly installments from May 25, 2009 through
April 25, 2011; 15,000 shares on August 1, 2009;
15,000 shares on August 1, 2010. |
|
(10) |
|
These shares of restricted stock vest as follows:
6,666 shares on February 12, 2009; 1,333 shares
on June 9, 2009; 6,668 shares on February 12,
2010; 1,333 shares on June 9, 2010; 1,334 shares
on June 9, 2011. |
The following table sets forth information concerning option
exercises and stock awards vested during the fiscal year ended
December 31, 2008 for the Named Executive Officers:
Option
Exercises
and Stock Vested
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
Shares Acquired
|
|
|
Value Realized
|
|
|
Shares Acquired
|
|
|
Value Realized
|
|
Name
|
|
on Exercise (#)
|
|
|
on Exercise ($)
|
|
|
on Vesting (#)
|
|
|
on Vesting ($)(1)
|
|
|
Douglas J. Wall
|
|
|
|
|
|
$
|
|
|
|
|
33,333
|
|
|
$
|
904,658
|
|
John E. Vollmer III
|
|
|
300,000
|
(2)
|
|
$
|
6,267,640
|
(3)
|
|
|
33,885
|
|
|
$
|
957,242
|
|
Mark S. Siegel
|
|
|
275,900
|
(4)
|
|
$
|
5,342,421
|
(5)
|
|
|
67,770
|
|
|
$
|
1,914,484
|
|
Kenneth N. Berns
|
|
|
133,600
|
(6)
|
|
$
|
2,596,276
|
(7)
|
|
|
33,885
|
|
|
$
|
957,242
|
|
William L. Moll, Jr.
|
|
|
|
|
|
$
|
|
|
|
|
6,666
|
|
|
$
|
147,252
|
|
|
|
|
(1) |
|
Value realized on vesting is based on the closing price of
Patterson-UTI Common Stock on the day immediately prior to the
date at which the respective shares vested. |
|
(2) |
|
Options were exercised on May 13, 2008. Includes 190,000
options with an exercise price of $13.195 per share and 110,000
options with an exercise price of $8.06 per share. |
|
(3) |
|
Value is based on the price at which shares received on exercise
were sold. The weighted average sales price was $32.20 per share. |
|
(4) |
|
Options were exercised on May 6, 2008. Includes 175,900
options with an exercise price of $13.195 per share and 100,000
options with an exercise price of $7.925 per share. |
|
(5) |
|
Value is based on the price at which shares received on exercise
were sold. The weighted average sales price was $30.65 per share. |
|
(6) |
|
Options were exercised on May 6, 2008. Includes 83,600
options with an exercise price of $13.195 per share and 50,000
options with an exercise price of $7.925 per share. |
|
(7) |
|
Value is based on the price at which shares received on exercise
were sold. The weighted average sales price was $30.66 per share. |
Patterson-UTI provides no pension benefits for any of the Named
Executive Officers. None of the Named Executive Officers had any
items of nonqualified deferred compensation during 2008. As a
result, tables with respect to pension benefits and nonqualified
deferred compensation have not been provided.
15
DIRECTOR
COMPENSATION
The following table sets forth information concerning
compensation for the fiscal year ended December 31, 2008
with respect to the directors of Patterson-UTI who are not
executive officers:
Director
Compensation Table
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or Paid
|
|
|
|
|
|
|
|
|
All Other
|
|
|
|
|
|
|
in Cash
|
|
|
Stock Awards
|
|
|
Option Awards
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
($)
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)
|
|
|
($)
|
|
|
Charles O. Buckner
|
|
$
|
55,000
|
|
|
$
|
69,186
|
(3)
|
|
$
|
62,258
|
(3)
|
|
$
|
|
|
|
$
|
186,444
|
|
Curtis W. Huff
|
|
$
|
60,000
|
|
|
$
|
58,921
|
(4)
|
|
$
|
51,603
|
(5)
|
|
$
|
|
|
|
$
|
170,524
|
|
Terry H. Hunt
|
|
$
|
45,000
|
|
|
$
|
58,921
|
(4)
|
|
$
|
51,603
|
(5)
|
|
$
|
|
|
|
$
|
155,524
|
|
Kenneth R. Peak
|
|
$
|
50,000
|
|
|
$
|
58,921
|
(4)
|
|
$
|
51,603
|
(5)
|
|
$
|
|
|
|
$
|
160,524
|
|
Cloyce A. Talbott
|
|
$
|
|
|
|
$
|
810,054
|
(6)
|
|
$
|
1,531,592
|
(7)
|
|
$
|
250,000
|
(8)
|
|
$
|
2,591,646
|
|
|
|
|
(1) |
|
Amounts set forth represent the dollar amount of expense
recognized for financial statement reporting purposes for the
fiscal year ended December 31, 2008 in accordance with
FAS 123R with respect to restricted stock held by the
director. For additional information related to the assumptions
used and valuation of restricted stock, see Note 10 to the
consolidated financial statements in Patterson-UTIs Annual
Report on
Form 10-K
for the fiscal year ended December 31, 2008. |
|
(2) |
|
Amounts set forth represent the dollar amount of expense
recognized for financial statement reporting purposes for the
fiscal year ended December 31, 2008 in accordance with
FAS 123R with respect to stock options held by the
director. For additional information related to the assumptions
used in connection with the valuation of stock options using the
Black-Scholes option pricing model, see Note 10 to the
consolidated financial statements in Patterson-UTIs Annual
Report for the fiscal year ended December 31, 2008. |
|
(3) |
|
Mr. Buckner received an award of 3,000 shares of
restricted stock and options to purchase 10,000 shares of
Common Stock on February 28, 2007 upon his joining the
Board of Directors. The stock award and options fully vested on
February 28, 2008. The grant date fair value of the stock
award was $22.29 per share. The grant date fair value of the
options was $6.94 per share. Mr. Buckner received an
additional award of 3,000 shares of restricted stock and
options to purchase 10,000 shares of Common Stock on
January 1, 2008. This award of restricted stock and options
fully vested on January 1, 2009. The grant date fair value
of the stock award was $19.52 per share. The grant date fair
value of the options was $5.10 per share. For the fiscal year
ended December 31, 2008, $10,626 was recognized as expense
associated with the February 28, 2007 stock award and
$58,560 was recognized as expense associated with the
January 1, 2008 stock award. For the fiscal year ended
December 31, 2008, $11,220 was recognized as expense
associated with the February 28, 2007 stock options and
$51,038 was recognized as expense associated with the
January 1, 2008 options. As of December 31, 2008,
Mr. Buckner held options to purchase a total of
20,000 shares of Common Stock, of which options to purchase
10,000 shares were unvested. As of December 31, 2008,
Mr. Buckner held 3,000 shares of unvested restricted
stock. |
|
(4) |
|
Messrs. Huff, Hunt and Peak each received an award of
3,000 shares of restricted stock on January 3, 2007
with a market value of $21.95 per share which fully vested on
January 3, 2008, and each received an award of
3,000 shares of restricted stock on January 1, 2008
with a market value of $19.52 per share which fully vested on
January 1, 2009. The amount presented includes $58,560
related to the January 1, 2008 grant and includes $361
related to the January 3, 2007 grant. As of
December 31, 2008, Messrs. Huff, Hunt and Peak each
held 3,000 unvested shares of restricted stock. |
|
(5) |
|
Messrs. Huff, Hunt and Peak each received options to
purchase 10,000 shares of stock on January 3, 2007
with a market value of $6.87 per share which fully vested on
January 3, 2008, and each received options to purchase
10,000 shares of stock on January 1, 2008 with a
market value of $5.10 per share, which fully vested on
January 1, 2009. The amount presented includes $51,038
related to the January 1, 2008 options and includes $565
related to the January 3, 2007 options. As of
December 31, 2008, Messrs. Huff and Hunt each held
options to purchase a total of 50,000 shares of Common
Stock, of which options to purchase 10,000 shares were
unvested. As of December 31, 2008, Mr. Peak held
options to purchase a total of 30,000 shares of Common
Stock, of which options to purchase 10,000 shares were
unvested. |
16
|
|
|
(6) |
|
Mr. Talbott was formerly the Chief Executive Officer of
Patterson-UTI. In this role, he was awarded 50,000 shares
of restricted stock on April 28, 2004 with a market value
of $19.14 per share, 30,000 shares of restricted stock on
April 27, 2005 with a market value of $24.63 per share,
30,000 shares of restricted stock on August 1, 2006
with a market value of $28.16 per share and 50,000 shares
of restricted stock on April 23, 2007 with a market value
of $24.17 per share. During 2008, a total of 67,770 shares
of Mr. Talbotts restricted stock vested consisting of
25,000 shares from the April 28, 2004 grant,
15,000 shares from the April 27, 2005 grant and
27,770 shares from the April 23, 2007 grant. The
expense amount presented in the table includes $38,345 related
to the April 28, 2004 grant, $131,750 related to the
April 27, 2005 grant, $247,061 related to the
August 1, 2006 grant and $392,898 related to the
April 23, 2007 grant. As of December 31, 2008,
Mr. Talbott held 67,230 shares of unvested restricted
stock. |
|
(7) |
|
In Mr. Talbotts former role as the Chief Executive
Officer of Patterson-UTI, he was awarded options to purchase
150,000 shares of stock on April 27, 2005 with a
market value of $6.33 per share, options to purchase
250,000 shares of stock on August 1, 2006 with a
market value of $8.58 per share and options to purchase
300,000 shares of stock on April 23, 2007 with a
market value of $7.15 per share. During 2008, options to
purchase a total of 266,666 shares vested consisting of
16,667 shares from the April 27, 2005 option,
83,333 shares from the August 1, 2006 option and
166,666 shares from the April 23, 2007 option. The
expense amount presented in the table includes $101,466 related
to the April 27, 2005 option, $714,904 related to the
August 1, 2006 option and $715,222 related to the
April 23, 2007 option. As of December 31, 2008,
Mr. Talbott held options to purchase a total of
1,200,000 shares of Common Stock, of which options to
purchase 188,890 shares were unvested. |
|
(8) |
|
Mr. Talbott retired from his position as President and
Chief Executive Officer of Patterson-UTI on September 30,
2007. Patterson-UTI entered into an employment agreement with
Mr. Talbott effective October 1, 2007 which provided
for the employment of Mr. Talbott on a part-time basis for
a period of five years. Mr. Talbotts salary during
the term of this employment agreement is $250,000 per year. |
Directors who are also employees of Patterson-UTI do not receive
compensation for serving as a director or as a member of a
committee of the Board of Directors. All directors are
reimbursed for reasonable
out-of-pocket
expenses incurred in connection with serving as a member of the
Board of Directors. Each non-employee director receives annual
cash compensation of $35,000 and (i) 3,000 shares of
restricted stock subject to one-year vesting (subject to
acceleration in certain limited situations, including a change
of control) and (ii) an option to purchase
10,000 shares of Common Stock at an exercise price equal to
the closing price of Common Stock on the grant date. The option
has a
10-year
term, vests after one-year (subject to acceleration in certain
limited situations, including a change of control) and contains
a right to exercise for three years following cessation of the
holder as a director (but not beyond the
10-year
term). Each non-employee director that serves on the Audit
Committee or the Compensation Committee receives additional
annual cash compensation of $10,000 per committee on which he
serves, with the chairman of each such committee receiving
$15,000.
CHANGE IN
CONTROL ARRANGEMENTS; EMPLOYMENT CONTRACTS;
INDEMNIFICATION AGREEMENTS; CERTAIN PAYMENTS
Patterson-UTI has entered into change in control agreements with
Messrs. Siegel, Wall, Berns, Vollmer and Moll (each
agreement, an Agreement and collectively, the
Agreements; and each individual, an Employee
and collectively, the Employees). The Agreements
were entered into to protect the Employees should a change in
control occur, thereby encouraging the Employee to remain in the
employ of Patterson-UTI and not be distracted from the
performance of his duties to Patterson-UTI by the possibility of
a change in control.
In the event of a change in control of Patterson-UTI in which an
Employees employment is terminated by Patterson-UTI other
than for cause or by the Employee for good reason, the terms of
the Agreements would entitle the Employee to, among other things:
|
|
|
|
|
a bonus payment equal to the highest bonus paid after the
Agreement was entered into (such bonus payment prorated for the
portion of the fiscal year preceding the termination date),
|
|
|
|
a payment equal to 2.5 times (in the case of Messrs. Siegel
and Wall), 2.0 times (in the case of Messrs. Berns and
Vollmer) or 1.5 times (in the case of Mr. Moll) of the sum
of (i) the highest annual salary in effect for
|
17
|
|
|
|
|
such Employee during the term of the Agreement and (ii) the
average of the three annual bonuses earned by the Employee for
the three fiscal years preceding the termination date (or a
benchmark bonus in the case of Messrs. Wall and
Moll), and
|
|
|
|
|
|
continued coverage under Patterson-UTIs welfare plans for
up to three years (in the case of Messrs. Siegel and Wall)
or two years (in the case of Messrs. Berns, Vollmer and
Moll).
|
Each Agreement provides the Employee with a full
gross-up
payment for any excise taxes imposed on payments and benefits
received under the Agreements or otherwise, including other
taxes that may be imposed as a result of the
gross-up
payment.
A change in control is principally defined by the
Agreement as:
|
|
|
|
|
an acquisition by any individual, entity or group of beneficial
ownership of 35% or more of either
Patterson-UTIs
then outstanding Common Stock or the combined voting power of
the then outstanding voting securities of Patterson-UTI entitled
to vote in the election of directors,
|
|
|
|
a change occurs in which the members of the Board of Directors
as of the date of the Agreement cease to constitute at least a
majority of Patterson-UTIs Board of Directors unless that
change occurs through a vote of at least a majority of the
incumbent members of the Board of Directors, or
|
|
|
|
a change in the beneficial ownership of Patterson-UTI following
consummation of a reorganization, merger, consolidation, sale of
Patterson-UTI or any subsidiary of Patterson-UTI or a
disposition of all or substantially all of the assets of
Patterson-UTI, in which the beneficial owners immediately prior
to the transaction own 65% or less of outstanding Common Stock
of the newly combined or merged entity.
|
The Agreements terminate on the first to occur of:
|
|
|
|
|
the Employees death, disability or retirement,
|
|
|
|
the termination of the Employees employment, or
|
|
|
|
January 29, 2010 although, unless otherwise terminated, the
Agreements automatically renew for successive twelve-month
periods until Patterson-UTI notifies the Employee at least
90 days before the expiration of the initial term or the
renewal period, as applicable, that the term will not be
extended. Patterson-UTI has not provided any such notification
to the Employees.
|
All unvested stock options and restricted stock awards held by
Named Executive Officers vest upon a change of control as
defined by the underlying award agreements. All restricted stock
awards held by Named Executive Officers contain provisions that
in the event of termination due to death or disability, the
Named Executive Officer would vest in a portion of the unvested
restricted stock.
Patterson-UTI has entered into written letter agreements with
each of Messrs. Siegel, Berns and Vollmer pursuant to which
Patterson-UTI has agreed to pay each such person within ten days
of the termination of his employment with Patterson-UTI for any
reason (including voluntary termination by him), an amount in
cash equal to his annual base salary at the time of such
termination. Patterson-UTI has entered into a severance
agreement with Mr. Wall that generally has a three-year
term and provides for a lump-sum cash payment of $750,000 to be
payable to Mr. Wall within ten days of the date of a
qualifying termination of his employment with Patterson-UTI. A
qualifying termination for Mr. Wall is defined in the
severance agreement generally as a termination by Patterson-UTI
for any reason other than cause or, if certain conditions are
met, a termination by Mr. Wall due to a reduction in his
annual base salary below a defined threshold amount. Any payment
made by Patterson-UTI pursuant to these letter agreements or the
severance agreement will reduce dollar for dollar any payment
owed to such person, if any, pursuant to the change in control
agreements discussed above.
18
Amounts that each of the Named Executive Officers would be
entitled to under the existing Agreements if a change in control
had occurred as of December 31, 2008 and the
employees employment was terminated by Patterson-UTI other
than for cause or by the employee for good reason (as defined in
the Agreements) are reflected in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Payments
|
|
|
Other Benefits
|
|
|
|
|
|
|
Bonus
|
|
|
Salary and
|
|
|
Option
|
|
|
Stock
|
|
|
Continued
|
|
|
|
|
|
|
Payment
|
|
|
Bonus
|
|
|
Awards
|
|
|
Awards
|
|
|
Benefits
|
|
|
Total
|
|
Name
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)(3)
|
|
|
($)(4)
|
|
|
($)
|
|
|
Douglas J. Wall
|
|
$
|
800,000
|
|
|
$
|
3,500,000
|
|
|
$
|
|
|
|
$
|
1,587,425
|
|
|
$
|
9,126
|
|
|
$
|
5,896,551
|
|
John E. Vollmer III
|
|
$
|
1,375,000
|
|
|
$
|
3,131,367
|
|
|
$
|
|
|
|
$
|
933,634
|
|
|
$
|
6,075
|
|
|
$
|
5,446,076
|
|
Mark S. Siegel
|
|
$
|
2,750,000
|
|
|
$
|
6,245,083
|
|
|
$
|
|
|
|
$
|
1,867,267
|
|
|
$
|
|
|
|
$
|
10,862,350
|
|
Kenneth N. Berns
|
|
$
|
1,375,000
|
|
|
$
|
2,728,033
|
|
|
$
|
|
|
|
$
|
933,634
|
|
|
$
|
|
|
|
$
|
5,036,667
|
|
William L. Moll, Jr.
|
|
$
|
100,000
|
|
|
$
|
525,000
|
|
|
$
|
|
|
|
$
|
199,514
|
|
|
$
|
15,350
|
|
|
$
|
839,864
|
|
|
|
|
(1) |
|
The assumed bonus payment is equal to the highest annual bonus
paid from the time the Agreements were entered into through
December 31, 2008. |
|
(2) |
|
The assumed salary and bonus payment represents 2.5 times (in
the case of Messrs. Siegel and Wall), 2.0 times (in the
case of Messrs. Berns and Vollmer) or 1.5 times (in the
case of Mr. Moll) of the sum of the 2008 salary in effect
for each employee and the average of the annual bonuses earned
by each employee for 2007, 2006 and 2005 (or a benchmark bonus
in the case of Messrs. Wall and Moll). Bonus amounts earned
in 2008 were not considered in this calculation as they were not
determined until after December 31, 2008. |
|
(3) |
|
Each of the Named Executive Officers option and stock
award agreements provide that unvested options and awards will
immediately vest upon a change in control. Amounts presented in
the table represent the value of unvested option and stock
awards using the market price of Patterson-UTI Common Stock at
December 31, 2008. All unvested options held by the Named
Executive Officers as of December 31, 2008 had exercise
prices that were greater than the market price of Patterson-UTI
Common Stock at December 31, 2008. |
|
(4) |
|
Messrs. Wall, Vollmer and Moll participated in
Patterson-UTIs health and welfare plans as of
December 31, 2008. The amounts presented represent
Patterson-UTIs portion of the premiums for three years in
the case of Mr. Wall and two years in the case of
Messrs. Vollmer and Moll based on the rates in effect at
December 31, 2008. |
All restricted stock awards held by Named Executive Officers
provide that in the event of termination of employment due to
death or disability, the Named Executive Officer would vest in a
portion of the unvested restricted stock. With respect to
Mr. Siegel, such a termination at December 31, 2008
would have resulted in the accelerated vesting of
60,462 shares with a fair value of $695,918. With respect
to Messrs. Vollmer and Berns, such a termination at
December 31, 2008 would have resulted in the accelerated
vesting of 30,229 shares with a fair value of $347,936.
With respect to Mr. Wall, such a termination would have
resulted in the accelerated vesting of 40,583 shares with a
fair value of $467,110. With respect to Mr. Moll, such a
termination would have resulted in the accelerated vesting of
6,654 shares with a fair value of $76,588.
Patterson-UTI has entered into an indemnification agreement with
each of its Named Executive Officers and directors containing
provisions that may require Patterson-UTI, among other things,
to indemnify such executive officers and directors against
liabilities that may arise by reason of their status or service
as executive officers or directors (subject to certain
exceptions) and to advance expenses incurred as a result of any
proceeding against them as to which they could be indemnified.
CERTAIN
TRANSACTIONS
In connection with the acquisition by REMY Capital Partners III,
L.P. (REMY Capital) of an ownership interest in UTI
in March 1995, REMY Capital succeeded to a registration rights
agreement with UTI. As the
successor-in-interest
to UTI, Patterson-UTI assumed this registration rights agreement
pursuant to which REMY Capital has the right to require
Patterson-UTI to use its reasonable efforts to register shares
held by REMY Capital under the Securities Act of 1933, as
amended. In the event that such rights are exercised in
connection with a primary offering proposed by Patterson-UTI (or
a secondary offering with which Patterson-UTI agrees to
19
participate), REMY Capital would bear its pro rata share of the
costs of the offering, other than legal, accounting and printing
costs, all of which Patterson-UTI would bear. In the event that
REMY Capital elects to exercise such rights other than in
connection with an offering in which Patterson-UTI participates,
REMY Capital would bear all costs of the offering. These rights
continue so long as REMY Capital continues to own the Common
Stock that it acquired in March 1995. As of the date of this
proxy statement, REMY Capital continues to hold
1,000,000 shares of Common Stock.
Mr. Siegel, Chairman of the Board of Patterson-UTI, is
President and sole stockholder of REMY Investors, which is the
general partner of REMY Capital. Mr. Berns, a director and
Senior Vice President of Patterson-UTI, is an executive of REMY
Investors.
In connection with Mr. Vollmers appointment as Chief
Financial Officer, Patterson-UTI delivered a letter to
Mr. Vollmer dated February 6, 2006 (the Letter
Agreement). Pursuant to the Letter Agreement,
Patterson-UTI agreed, to the extent permitted by law and
provided that the applicable accounting restatement pending at
that time did not result from Patterson-UTIs material
non-compliance with financial reporting requirements under the
federal securities laws as a result of knowing misconduct by
Mr. Vollmer:
|
|
|
|
|
Patterson-UTI is not entitled to and will not make any claim
against Mr. Vollmer for reimbursement of any bonus or other
incentive or equity based compensation received by him or any
profits realized by him from the sale of securities of
Patterson- UTI, under Section 304 of the Sarbanes-Oxley Act
of 2002 (Section 304) on account of the
restatement of any financial statements of Patterson-UTI
covering any accounting period ending on or prior to
September 30, 2005;
|
|
|
|
Patterson-UTI will not make any claim against Mr. Vollmer
for any profits realized from the sale of securities of
Patterson-UTI that were owned by him prior to his becoming Chief
Financial Officer or were acquired by him on account of the
exercise of options or the settling of restricted stock units
that were held by him immediately prior to his becoming Chief
Financial Officer, under Section 304 on account of the
restatement of any financial statements of Patterson-UTI
covering any period during which he was Chief Financial
Officer; and
|
|
|
|
Patterson-UTI will indemnify Mr. Vollmer against all losses
in connection with his defense of any claim against him under
Section 304 in contravention of the two immediately
preceding bullets, to the extent he is obligated to reimburse
Patterson-UTI for any bonus or other incentive or equity
compensation received by him or any profits realized by him for
the sale of Patterson-UTI securities.
|
Notwithstanding court decisions that Patterson-UTIs right
to make any such claims appears doubtful, Patterson-UTI has
entered into this agreement because of the breadth of language
of Section 304 and the uncertainty as to how the statute
may be interpreted by the courts in the future and the
importance at the time of Mr. Vollmers continued
service as Chief Financial Officer.
Patterson-UTI has a written policy with respect to related
person transactions. In accordance with this policy, related
person transactions are reviewed by the Lead Director or the
chair of the Audit Committee, each of whom has full delegated
authority to approve, disapprove, ratify, amend, terminate or
rescind any such transaction, or direct that such transaction be
submitted to the Audit Committee or the full Board of Directors
for consideration. In approving or disapproving related person
transactions, the relevant facts and circumstances of the
related person transaction are considered, including whether
such transaction is in, or not inconsistent with, the best
interest of Patterson-UTI and whether, in appropriate cases,
such transaction is on commercial terms at least as favorable to
Patterson-UTI as would otherwise be available to or from an
unrelated third party or to Patterson-UTIs employees
generally. Related person transactions generally include
transactions in an amount that exceeds $50,000 between
Patterson-UTI or any of its subsidiaries and an executive
officer, a director (or nominee to become director), an
immediate family member of any of the foregoing or any entity in
which any of the foregoing has a 10% or greater beneficial
ownership interest or in which they are an executive officer,
general partner, principal or engaged in a similar position.
Certain related person transactions have been pre-approved under
the terms of the policy, including, subject to certain
exceptions and limitations, the sale to or purchase from
Patterson-UTI of goods and services by entities related to
directors in the ordinary course of business that are immaterial
to Patterson-UTI and with respect to which the director has no
direct economic interest or decision making authority.
20
SECURITY
OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth, as of April 16, 2009, the
stock ownership of (i) the Named Executive Officers,
directors and Board nominees, individually, (ii) all
directors, Board nominees and executive officers as a group and
(iii) each person known by Patterson-UTI to be the
beneficial owner of more than 5% of Common Stock.
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
|
|
Name of
|
|
Beneficial
|
|
|
Percent
|
|
Beneficial Owner
|
|
Ownership
|
|
|
of Class
|
|
|
Beneficial Owners of more than 5% of Patterson-UTIs Common
Stock:
|
|
|
|
|
|
|
|
|
First Pacific Advisors, LLC
|
|
|
11,261,076
|
(1)
|
|
|
7.4
|
%
|
FMR LLC
|
|
|
9,931,445
|
(2)
|
|
|
6.5
|
%
|
Barclays Global Investors, NA
|
|
|
9,363,768
|
(3)
|
|
|
6.1
|
%
|
Directors and Executive Officers:
|
|
|
|
|
|
|
|
|
Mark S. Siegel
|
|
|
2,447,388
|
(4)
|
|
|
1.6
|
%
|
Douglas J. Wall
|
|
|
292,306
|
(5)
|
|
|
|
*
|
John E. Vollmer III
|
|
|
920,695
|
(6)
|
|
|
|
*
|
Kenneth N. Berns
|
|
|
718,695
|
(7)
|
|
|
|
*
|
William L. Moll, Jr.
|
|
|
21,823
|
(8)
|
|
|
|
*
|
Charles O. Buckner
|
|
|
29,000
|
(9)
|
|
|
|
*
|
Curtis W. Huff
|
|
|
92,880
|
(10)
|
|
|
|
*
|
Terry H. Hunt
|
|
|
70,800
|
(11)
|
|
|
|
*
|
Kenneth R. Peak
|
|
|
47,000
|
(12)
|
|
|
|
*
|
Cloyce A. Talbott
|
|
|
1,443,920
|
(13)
|
|
|
|
*
|
All directors and executive officers as a group (11 persons)
|
|
|
6,102,389
|
(14)
|
|
|
3.9
|
%
|
|
|
|
* |
|
indicates less than 1.0% |
|
(1) |
|
Based solely on a Schedule 13G jointly filed by First
Pacific Advisors, LLC (First Pacific),
Robert L. Rodriguez and J. Richard Atwood with the SEC
on February 11, 2009. According to the report, First
Pacific, in its capacity as investment advisor to various of its
clients, has shared voting power with respect to
4,996,900 shares and shared dispositive power with respect
to 11,261,076 shares. Robert L. Rodriguez has shared voting
power with respect to 4,996,900 shares and shared
dispositive power with respect to 11,261,076 shares. J.
Richard Atwood has shared voting power with respect to
4,996,900 shares and shared dispositive power with respect
to 11,261,076 shares. Robert L. Rodriguez and J. Richard
Atwood are each part owners and managing members of First
Pacific and are deemed to beneficially own
11,261,076 shares of Patterson-UTI owned by First
Pacifics clients. Robert L. Rodriguez and J. Richard
Atwood disclaim beneficial ownership of the securities owned by
First Pacifics clients. The address of the principal
business office of First Pacific and of Robert L. Rodriguez and
J. Richard Atwood is 11400 West Olympic Blvd., Suite 1200,
Los Angeles, CA 90064. |
|
(2) |
|
Based solely on a Schedule 13G/A filed March 10, 2009,
jointly on behalf of FMR LLC (FMR), Edward C.
Johnson 3d, and Fidelity Management & Research
Company, a wholly-owned subsidiary of FMR
(Fidelity). According to the report, the shares are
beneficially owned as follows: Fidelity
9,727,440 shares; Pyramis Global Advisors LLC, an indirect
wholly-owned subsidiary of FMR (PGALLC)
50,600 shares; Pyramis Global Advisors Trust Company, an
indirect wholly-owned subsidiary of FMR
(PGATC) 152,700 shares; FIL Limited
(FIL) 705 shares. FMR and FIL are
of the view that the shares held by the other entity need not be
aggregated for purposes of Section 13(d) under the
Securities Exchange Act of 1934, but FMR filed the report on a
voluntary basis as if all of the shares are beneficially owned
by FMR and FIL on a joint basis. The Fidelity Funds Board
of Trustees has sole voting power over the shares that are
beneficially owned by Fidelity, and Edward C. Johnson 3d and
FMR, through control of Fidelity and the Fidelity Funds, each
has sole dispositive power over the 9,727,440 shares owned
by the Fidelity Funds. Edward C. Johnson 3d and FMR, through
control of PGALLC, PGATC, and FMR LLC subsidiaries, each has
sole dispositive power and sole |
21
|
|
|
|
|
power to vote or direct the voting of the shares beneficially
owned by PGALLC and PGATC. FIL and various foreign-based
subsidiaries of FMR provide investment advisory and management
services to a number of
non-U.S.
investment companies and certain institutional investors.
Partnerships controlled predominantly by members of the family
of Edward C. Johnson 3d, or trusts for their benefit, own shares
of voting stock of FIL with the right to cast approximately 47%
of the total votes which may be cast by all holders of FIL
voting stock. FMR and FIL are separate and independent corporate
entities and their Boards of Directors are generally composed of
different individuals. The address of FMR, Edward C. Johnson 3d
and Fidelity is 82 Devonshire Street, Boston, MA 02109. The
address of PGALLC and PGATC is 53 State Street, Boston, MA
02109. The address of FIL is Pembroke Hall, 42 Crow Lane,
Hamilton, Bermuda. |
|
(3) |
|
Based solely on a Schedule 13G filed jointly by Barclays
Global Investors, NA (Barclays Investors), Barclays
Global Fund Advisors (Barclays Advisors),
Barclays Global Investors, Ltd. (Barclays Ltd.),
Barclays Global Investors Japan Limited (Barclays
Japan), Barclays Global Investors Canada Limited
(Barclays Canada) and Barclays Global Investors
Australia Limited (Barclays Australia) with the SEC
on February 5, 2009. According to the report, Barclays
Investors has sole voting power with respect to
3,306,441 shares and sole dispositive power with respect to
3,897,757 shares. Barclays Advisors has sole voting power
with respect to 3,750,730 shares and sole dispositive power
with respect to 4,623,764 shares. Barclays Ltd. has sole
voting power with respect to 416,698 shares and sole
dispositive power with respect to 563,976 shares. Barclays
Japan has sole voting and dispositive power with respect to
252,771 shares. Barclays Canada has sole voting and
dispositive power with respect to 4,887 shares. Barclays
Australia has sole voting and dispositive power with respect to
20,613 shares. The address of the principal business office
of Barclays Investors and Barclays Advisors is 400 Howard
Street, San Francisco, California 94105. The address of the
principal business office of Barclays Ltd. is Murray House, 1
Royal Mint Court, London EC3N 4HH. The address of the principal
business office of Barclays Japan is Ebisu Prime Square Tower
8th Floor, 1-1-39 Hiroo Shibuya-Ku, Tokyo, Japan
150-0012.
The address of the principal business office of Barclays Canada
is Brookfield Place 161 Bay Street, Suite 2500, Toronto,
Canada Ontario M5J 2S1. The address of the principal business
office of Barclays Australia is Level 43, Grosvenor Place,
225 George Street, Sydney, Australia NSW 1220. |
|
(4) |
|
Mr. Siegel is the President and sole stockholder of REMY
Investors, which is the general partner of REMY Capital Partners
III, L.P. (REMY Capital). The Common Stock
beneficially owned by Mr. Siegel includes
1,000,000 shares of Common Stock owned by REMY Capital. The
Common Stock beneficially owned by Mr. Siegel also includes
stock options held by Mr. Siegel, which are presently
exercisable or become exercisable within sixty days, to purchase
1,180,388 shares of Common Stock, but does not include
257,612 shares underlying stock options held by
Mr. Siegel that are not presently exercisable and will not
become exercisable within sixty days. Includes
158,066 shares of unvested restricted Common Stock held by
Mr. Siegel, over which he presently has voting power. |
|
(5) |
|
Includes shares underlying stock options held by Mr. Wall,
which are presently exercisable or become exercisable within
sixty days, to purchase 132,514 shares of Common Stock, but
does not include 145,986 shares underlying stock options
held by Mr. Wall that are not presently exercisable and
will not become exercisable within sixty days. Includes
104,584 shares of unvested restricted Common Stock held by
Mr. Wall, over which he presently has voting power. |
|
(6) |
|
Includes shares underlying stock options held by
Mr. Vollmer, which are presently exercisable or become
exercisable within sixty days, to purchase 800,195 shares.
Does not include 128,805 shares underlying stock options
held by Mr. Vollmer that are not presently exercisable and
will not become exercisable within sixty days. Includes
79,033 shares of unvested restricted Common Stock held by
Mr. Vollmer, over which he presently has voting power. |
|
(7) |
|
Includes shares underlying stock options held by Mr. Berns,
which are presently exercisable or become exercisable within
sixty days, to purchase 590,195 shares. Does not include
128,805 shares underlying stock options that are not
presently exercisable and will not become exercisable within
sixty days. Includes 79,033 shares of unvested restricted
Common Stock held by Mr. Berns, over which he presently has
voting power. Does not include shares of Common Stock
beneficially owned by REMY Investors. Mr. Berns disclaims
beneficial ownership of such shares beneficially owned by REMY
Investors. |
22
|
|
|
(8) |
|
Includes 10,668 shares of unvested restricted Common Stock
held by Mr. Moll, over which he presently has voting power. |
|
(9) |
|
Includes shares underlying presently exercisable stock options
held by Mr. Buckner to purchase 20,000 shares. Does
not include 10,000 shares underlying stock options held by
Mr. Buckner that are not presently exercisable and will not
become exercisable within sixty days. Includes 3,000 shares
of unvested restricted Common Stock held by Mr. Buckner,
over which he presently has voting power. |
|
(10) |
|
Includes shares underlying presently exercisable stock options
held by Mr. Huff to purchase 50,000 shares. Does not
include 10,000 shares underlying stock options held by
Mr. Huff that are not presently exercisable and will not
become exercisable within sixty days. Includes 3,000 shares
of unvested restricted Common Stock held by Mr. Huff, over
which he presently has voting power. |
|
(11) |
|
Includes 800 shares of Common Stock owned by
Mr. Hunts
mother-in-law,
over which Mr. Hunt presently has shared voting power.
Includes shares underlying presently exercisable stock options
held by Mr. Hunt to purchase 50,000 shares. Does not
include 10,000 shares underlying stock options held by
Mr. Hunt that are not presently exercisable and will not
become exercisable within sixty days. Includes 3,000 shares
of unvested restricted Common Stock held by Mr. Hunt, over
which he presently has voting power. |
|
(12) |
|
Includes shares underlying presently exercisable stock options
held by Mr. Peak to purchase 30,000 shares. Does not
include 10,000 shares underlying stock options held by
Mr. Peak that are not presently exercisable and will not
become exercisable within sixty days. Includes 3,000 shares
of unvested restricted Common Stock held by Mr. Peak, over
which he presently has voting power. |
|
(13) |
|
Includes shares underlying stock options held by
Mr. Talbott, which are presently exercisable or become
exercisable within sixty days, to purchase
1,094,444 shares. Does not include 105,556 shares
underlying stock options held by Mr. Talbott that are not
presently exercisable and will not become exercisable within
sixty days. Includes 63,066 shares of unvested restricted
Common Stock held by Mr. Talbott, over which he presently
has voting power. |
|
(14) |
|
Includes shares underlying stock options, which are presently
exercisable or become exercisable within sixty days, to purchase
3,947,736 shares of Common Stock. Does not include shares
underlying stock options to purchase 806,764 shares held by
such individuals that are not presently exercisable and will not
become exercisable within sixty days. Includes 800 shares
of Common Stock over which a director presently has shared
voting power. Includes an aggregate of 524,332 shares of
unvested restricted Common Stock held by certain directors and
executive officers, over which they presently have voting power. |
Except as stated herein, each stockholder has sole voting and
investment power with respect to Common Stock included in the
above table. There are no arrangements known to Patterson-UTI
which may result in a change in control.
23
AUDIT
COMMITTEE REPORT
The following report of the Audit Committee does not constitute
soliciting material and should not be deemed filed or
incorporated by reference into any other Patterson-UTI filing
under the Securities Act of 1933, as amended, or the Exchange
Act, except to the extent Patterson-UTI specifically
incorporates this report by reference therein.
The Audit Committee has reviewed and discussed the audited
financial statements with management and Patterson-UTIs
independent registered public accounting firm.
The Audit Committee has discussed with the independent
registered public accounting firm the matters required to be
discussed by Statement on Auditing Standards No. 114,
The Auditors Communication with those Charged with
Governance (superseded Statement on Auditing Standards
No. 61, Communication with Audit Committees, as
amended), as adopted by the Public Company Accounting Oversight
Board in Rule 3200T.
The Audit Committee has received and reviewed the written
disclosures and the letter from the independent registered
public accounting firm required by applicable requirements of
the Public Company Accounting Oversight Board regarding the
independent registered public accounting firms
communications with the Audit Committee concerning independence,
and has discussed with the independent registered public
accounting firm their independence.
Taking the foregoing into consideration, the undersigned Audit
Committee members recommended to the Board of Directors that the
Board approve the inclusion of the Patterson-UTIs audited
financial statements in the Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008.
Audit Committee of the Board of Directors:
Curtis W. Huff, Chairman
Charles O. Buckner
Terry H. Hunt
PricewaterhouseCoopers
Fees for Fiscal Years 2008 and 2007
In 2008 and 2007, Patterson-UTI and its subsidiaries incurred
fees for services provided relating to (i) professional
services rendered for the audit of Patterson-UTIs annual
financial statements, review of quarterly financial statements,
and assessment of Patterson-UTIs internal controls over
financial reporting, (ii) professional services rendered
for tax compliance, advice and planning, and (iii) products
and services provided by PricewaterhouseCoopers LLP.
|
|
|
|
|
|
|
|
|
|
|
Fees Incurred in
|
|
|
Fees Incurred in
|
|
|
|
Fiscal Year
|
|
|
Fiscal Year
|
|
Description
|
|
2008
|
|
|
2007
|
|
|
Audit fees
|
|
$
|
1,201,750
|
|
|
$
|
1,150,000
|
|
Tax fees
|
|
|
45,000
|
|
|
|
45,000
|
|
All other fees
|
|
|
1,600
|
|
|
|
1,600
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,248,350
|
|
|
$
|
1,196,600
|
|
|
|
|
|
|
|
|
|
|
The Audit Committee appoints the independent registered public
accounting firm. The Audit Committee or Mr. Huff, as
Chairman of the Audit Committee, approves all other engagements
of the independent registered public accounting firm in advance.
In the event Mr. Huff approves any such engagement, he
discusses such approval with the Audit Committee at its next
meeting.
Audit fees relate to audit services of
PricewaterhouseCoopers LLP for fiscal 2008 and 2007 consisting
of the examination of Patterson-UTIs consolidated
financial statements, quarterly reviews of Patterson-UTIs
interim financial statements and services to assess
Patterson-UTIs internal control over financial reporting.
Tax fees include federal, state, local and foreign
tax compliance and related matters. All other fees
consists of an annual
24
subscription fee to a software product. The Audit Committee or
Mr. Huff, as Chairman of the Audit Committee, approved all
of the services described above.
The Audit Committee has discussed the non-audit services
provided by PricewaterhouseCoopers LLP and the related fees and
has considered whether those services and fees are compatible
with maintaining auditor independence. The Audit Committee
determined that such non-audit services were consistent with the
independence of PricewaterhouseCoopers LLP.
OTHER
MATTERS
Section 16(a)
Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires
Patterson-UTIs officers and directors and persons who own
more than 10 percent of a registered class of
Patterson-UTIs equity securities, to file reports of
ownership and changes in ownership with the SEC. Each of these
persons is required by SEC regulation to furnish Patterson-UTI
with copies of Section 16(a) filings. Based solely upon a
review of Forms 3 and 4 and amendments thereto furnished to
Patterson-UTI during 2008 and Forms 5 and amendments
thereto furnished to Patterson-UTI with respect to 2008, or a
written representation from the reporting person that no
Form 5 is required, all filings required to be made by such
officers, directors, and beneficial owners of more than
10 percent of a registered class of Patterson-UTIs
common stock were timely made.
Other
Business
As of the date of this proxy statement, management of
Patterson-UTI was not aware of any matter to be presented at the
Meeting other than as set forth herein. If any other matters are
properly brought before the Meeting, however, the shares
represented by valid proxies will be voted with respect to such
matters in accordance with the judgment of the persons voting
them.
Stockholder
Proposals for 2010 Annual Meeting
Proposals or Director Nominations for Inclusion in the Proxy
Statement. Pursuant to
Rule 14a-8
under the Exchange Act, stockholders may present proper
proposals or director nominations for inclusion in
Patterson-UTIs proxy statement and for consideration at
the next annual meeting of stockholders by submitting their
proposals or director nominations to Patterson-UTI in a timely
manner. In order to be included in Patterson-UTIs proxy
statement for the 2010 annual meeting of stockholders, proposals
or director nominations from stockholders must be received by
Patterson-UTI no later than December 17, 2009, and must
otherwise comply with the requirements of
Rule 14a-8.
Proposals or Director Nominations not Included in the Proxy
Statement. In addition, Patterson-UTIs
bylaws establish an advance notice procedure with regard to
stockholder proposals and director nominations not included in
Patterson-UTIs proxy statement. For director nominations
not included in Patterson-UTIs proxy statement, please
refer to Election of Directors Meetings and
Committees of the Board of Directors. For stockholder
proposals to be properly brought before the 2010 annual meeting,
by a stockholder, the stockholder must be a stockholder of
record on the date of the giving of the notice provided for
below and on the record date for the determination of
stockholders entitled to vote at such annual meeting and must
give timely notice of such business in writing to the Secretary
of Patterson-UTI. To be timely with respect to the 2010 annual
meeting, a stockholders notice must be delivered to or
mailed and received at Patterson-UTIs principal executive
offices not earlier than February 3, 2010 and not later
than March 5, 2010; provided, however, that in the event
that the annual meeting is called for a date that is not within
30 days before or after June 3, 2010, notice by the
stockholder to be timely must be received not later than the
close of business on the tenth day following the day on which
such notice of the date of the meeting was mailed or public
disclosure of the annual meeting date was made, whichever occurs
first.
A stockholders notice to the Secretary of Patterson-UTI
shall set forth:
|
|
|
|
|
a brief description of each matter desired to be brought before
the annual meeting and the reasons for conducting such business
at the annual meeting,
|
|
|
|
the name and record address of the stockholder proposing such
business,
|
25
|
|
|
|
|
the class and number of shares of Patterson-UTI that are
beneficially owned by the stockholder,
|
|
|
|
any material interest of the stockholder in such
business, and
|
|
|
|
a representation that such stockholder intends to appear in
person or by proxy at the annual meeting to bring such business
before the meeting.
|
The proxies will have discretionary authority to vote on any
matter that properly comes before the meeting if the stockholder
has not provided timely written notice as required by the
Patterson-UTI bylaws.
Patterson-UTI reserves the right to reject, rule out of order,
or take other appropriate action with respect to any proposal or
nomination that does not comply with these and other applicable
requirements.
Annual
Report
A copy of Patterson-UTIs annual report on
Form 10-K
(the Annual Report on
Form 10-K)
accompanies this proxy statement only if you have requested that
a copy of this proxy statement be mailed to you. The Annual
Report on
Form 10-K
also is available electronically by following the instructions
in the Notice. The Annual Report on
Form 10-K
is not incorporated into this proxy statement and is not
considered proxy-soliciting material.
A copy of the Annual Report on
Form 10-K,
excluding exhibits, may be obtained by stockholders without
charge by written request to the Secretary of Patterson-UTI at
450 Gears Road, Suite 500, Houston, Texas 77067 or may be
accessed on Patterson-UTIs website at www.patenergy.com in
the investors section under the financial reports
link.
26
|
|
|
|
|
TO VOTE, MARK BLOCKS BELOW
IN BLUE OR BLACK INK AS FOLLOWS: x |
|
|
|
KEEP THIS PORTION FOR YOUR RECORDS |
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. |
DETACH
AND RETURN THIS PORTION
ONLY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For All |
|
Withhold All |
|
For All Except |
|
To withhold authority to vote for any individual
nominee(s), mark For All Except
and write the
number(s) of the nominee(s) on the line below.
|
c |
|
|
|
The
Board of Directors recommends that you vote FOR the following: 1. Election of Directors |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01 |
Mark S. Siegel |
|
|
02 |
|
|
Kenneth N. Berns |
|
|
03 |
|
|
Charles O. Buckner |
|
|
04 |
|
|
Curtis W. Huff |
|
|
05 |
|
|
Terry H. Hunt |
06 |
Kenneth R. Peak |
|
|
07 |
|
|
Cloyce A. Talbott |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
Board of Directors recommends you vote FOR the following proposal(s) : |
|
|
|
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
|
|
|
|
2 |
Ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2009. |
|
o |
|
o |
|
o |
|
|
NOTE: In their discretion, the Proxies are authorized to vote upon such other
business as may properly come before the Meeting or any and all adjournments or postponements thereof. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney,
executor, administrator, or other fiduciary, please give full title as such. Joint owners
should each sign personally. All holders must sign. If a corporation,
partnership or other entity, please sign in
full corporate, partnership or other entity name, by authorized officer. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHARES |
|
|
|
|
|
|
|
|
|
|
CUSIP # SEQUENCE # |
Signature [PLEASE SIGN WITHIN
BOX] |
Date |
|
|
JOB # |
|
|
Signature (Joint Owners) |
Date |
|
|
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice &
Proxy Statement, Annual Report is/ are available at www.proxyvote.com.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PATTERSON-UTI ENERGY, INC. This Proxy is Solicited on Behalf of the Board of Directors
Proxy for Annual Meeting of Stockholders |
|
|
|
|
|
|
|
|
|
|
To be Held on June 3, 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The undersigned stockholder of Patterson-UTI Energy, Inc. (the Company) hereby appoints Mark S.
Siegel, Douglas J. Wall and John E. Vollmer III, and each of them, proxies of the undersigned, each
with full power to act without the other and with full power of substitution, to vote all of the
shares which the undersigned is entitled to vote at the annual meeting of stockholders of the
Company to be held on Wednesday, June 3, 2009, at 10:00 a.m., local time, at the Hilton Houston
North Hotel, 12400 Greenspoint Drive, Houston, Texas 77060, and at any and all adjournments or
postponements thereof, with the same force and effect as if the undersigned were personally
present. The undersigned hereby instructs the above-named proxies to vote the shares represented by
this proxy in the manner as directed for the undersigned on the reverse side of this proxy card. If
no directions are made, the proxies will vote FOR the nominees for directors and FOR the
ratification of the selection of PricewaterhouseCoopers LLP as set forth on the reverse side. If
any other matter should be presented properly, this proxy will be voted in accordance with the
discretion of the above-named proxies. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continued and to be marked, dated and signed on the reverse side
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|